RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Animal Disease Models |
|
Accession: | DOID:9006205
|
browse the term
|
Definition: | Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. |
Synonyms: | exact_synonym: | Animal Disease Model |
| primary_id: | MESH:D004195 |
| alt_id: | RDO:0005376 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16472600 PMID:29808285 |
|
NCBI chr14:13,542,610...13,614,334
Ensembl chr14:13,548,462...13,614,571
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23415960 |
|
NCBI chr 6:27,800,060...27,849,170
Ensembl chr 6:27,798,835...27,848,689
|
|
G |
ACSL4 |
acyl-CoA synthetase long chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:82,864,506...82,943,984
Ensembl chr X:82,866,823...82,916,789
|
|
G |
AHCY |
adenosylhomocysteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr24:23,410,553...23,423,494
Ensembl chr24:23,411,140...23,419,767
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
|
|
G |
AIF1 |
allograft inflammatory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25658812 PMID:32045588 |
|
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
|
|
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16642209 PMID:17963606 |
|
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
|
|
G |
ALDH18A1 |
aldehyde dehydrogenase 18 family member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr28:9,101,578...9,148,063
Ensembl chr28:9,102,282...9,147,992
|
|
G |
ALDH5A1 |
aldehyde dehydrogenase 5 family member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29031482 |
|
NCBI chr35:22,560,005...22,590,996
Ensembl chr35:22,560,008...22,587,875
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27466191 |
|
NCBI chr 2:77,559,791...77,614,102
Ensembl chr 2:77,559,791...77,614,820
|
|
G |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr30:32,741,582...32,778,883
Ensembl chr30:32,741,582...32,798,188
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:17,786,808...17,789,422
Ensembl chr15:17,786,357...17,789,422
|
|
G |
APP |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12746438 PMID:16651627 PMID:25881725 PMID:27567873 PMID:31939705 |
|
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
|
|
G |
AQP4 |
aquaporin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
|
|
G |
ARG1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:242,717...255,736
Ensembl chr12:242,714...255,305
|
|
G |
ARTN |
artemin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
|
|
G |
ATP7A |
ATPase copper transporting alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17483305 |
|
NCBI chr X:60,203,336...60,356,525
Ensembl chr X:60,203,270...60,352,869
|
|
G |
ATP7B |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11803042 PMID:15911138 PMID:21146535 PMID:21364284 |
|
NCBI chr22:162,474...225,599
Ensembl chr22:191,888...225,266
|
|
G |
AXIN2 |
axin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 9:14,559,476...14,588,950
Ensembl chr 9:14,559,388...14,588,530
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr 8:64,974,588...65,005,682
Ensembl chr 8:64,974,997...65,003,407
|
|
G |
BSCL2 |
BSCL2 lipid droplet biogenesis associated, seipin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25462787 |
|
NCBI chr18:53,958,380...53,971,120
Ensembl chr18:53,958,475...53,971,119
|
|
G |
BZW2 |
basic leucine zipper and W2 domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr14:31,154,285...31,217,193
Ensembl chr14:31,153,659...31,216,911
|
|
G |
CA2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15816485 |
|
NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579
|
|
G |
CACNA1D |
calcium voltage-gated channel subunit alpha1 D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26831068 |
|
NCBI chr20:36,189,986...36,488,460
Ensembl chr20:36,191,810...36,613,686
|
|
G |
CALY |
calcyon neuron specific vesicular protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30753204 |
|
NCBI chr28:40,918,341...40,925,161
Ensembl chr28:40,918,343...40,925,070
|
|
G |
CCT5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr34:4,035,851...4,049,131
Ensembl chr34:4,035,857...4,049,244
|
|
G |
CDH2 |
cadherin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr 7:60,736,760...60,950,477
Ensembl chr 7:60,736,760...60,951,034
|
|
G |
CLDN11 |
claudin 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25911099 |
|
NCBI chr34:34,912,903...34,929,441
Ensembl chr34:34,912,449...34,928,433
|
|
G |
CLN6 |
CLN6 transmembrane ER protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23789114 |
|
NCBI chr30:32,246,394...32,264,251
Ensembl chr30:32,246,411...32,264,240
|
|
G |
CLN8 |
CLN8 transmembrane ER and ERGIC protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22302580 |
|
NCBI chr37:30,863,098...30,885,831
Ensembl chr37:30,867,479...30,884,895
|
|
G |
CNR1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23072421 |
|
NCBI chr12:47,537,240...47,560,723
Ensembl chr12:47,509,583...47,560,983
|
|
G |
CNR2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27317300 |
|
NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
|
|
G |
COL2A1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17299831 |
|
NCBI chr27:6,756,994...6,787,733
Ensembl chr27:6,756,994...6,787,733
|
|
G |
CRSP-3 |
calcitonin receptor-stimulating peptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr21:37,676,841...37,680,643
Ensembl chr21:37,676,841...37,680,645
|
|
G |
CSF3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27737899 |
|
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
|
|
G |
CSRP3 |
cysteine and glycine rich protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr21:41,300,277...41,318,788
Ensembl chr21:41,300,425...41,318,738
|
|
G |
CTNNB1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
|
|
G |
CTU1 |
cytosolic thiouridylase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr 1:105,795,273...105,800,722
|
|
G |
CTU2 |
cytosolic thiouridylase subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr 5:64,640,389...64,647,298
Ensembl chr 5:64,640,389...64,647,215
|
|
G |
DEK |
DEK proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr35:17,014,802...17,045,308
Ensembl chr35:17,016,231...17,044,749
|
|
G |
DHCR7 |
7-dehydrocholesterol reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29698737 |
|
NCBI chr18:47,257,750...47,277,436
Ensembl chr18:47,261,730...47,274,236
|
|
G |
DMD |
dystrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22795790 PMID:26930420 PMID:30074247 |
|
NCBI chr X:26,290,903...28,444,635
Ensembl chr X:26,290,910...28,333,576
|
|
G |
DSTN |
destrin, actin depolymerizing factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr24:5,394,972...5,402,443
Ensembl chr24:5,356,464...5,432,574
|
|
G |
EIF2B1 |
eukaryotic translation initiation factor 2B subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr26:6,011,280...6,022,562
Ensembl chr26:6,011,301...6,022,518
|
|
G |
EIF3E |
eukaryotic translation initiation factor 3 subunit E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:8,834,724...8,887,818
Ensembl chr13:8,834,821...8,887,760
|
|
G |
ELP3 |
elongator acetyltransferase complex subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr25:29,415,229...29,507,159
Ensembl chr25:29,415,924...29,507,098
|
|
G |
ENO1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22302033 |
|
NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294
|
|
G |
ESR1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20962747 |
|
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21127298 |
|
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
|
|
G |
FAS |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22536412 PMID:26590112 |
|
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
|
|
G |
FASN |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:233,105...249,573
Ensembl chr 9:232,963...249,092
|
|
G |
FBL |
fibrillarin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:113,632,899...113,643,805
Ensembl chr 1:113,632,929...113,643,748
|
|
G |
FKBP11 |
FKBP prolyl isomerase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr27:5,636,643...5,639,521
Ensembl chr27:5,636,627...5,639,509
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 8:48,330,856...48,334,273
Ensembl chr 8:48,331,026...48,333,467
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr27:38,468,889...38,472,653
Ensembl chr27:38,468,889...38,472,385
|
|
G |
GAR1 |
GAR1 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr32:29,995,710...30,004,545
Ensembl chr32:29,996,148...30,004,536
|
|
G |
GATA4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
|
|
G |
GFAP |
glial fibrillary acidic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 9:18,569,868...18,579,463
Ensembl chr 9:18,569,892...18,579,461
|
|
G |
GLI2 |
GLI family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27585885 |
|
NCBI chr19:29,128,401...29,383,324
Ensembl chr19:29,130,227...29,383,658
|
|
G |
GNPNAT1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:28,992,173...29,005,511
Ensembl chr 8:28,993,227...29,005,435
|
|
G |
GOLM1 |
golgi membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:73,609,224...73,654,280
Ensembl chr 1:73,546,172...73,652,370
|
|
G |
GPI |
glucose-6-phosphate isomerase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:117,922,380...117,948,325
Ensembl chr 1:117,922,635...117,948,316
|
|
G |
GRIN1 |
glutamate ionotropic receptor NMDA type subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 9:48,492,967...48,513,981
Ensembl chr 9:48,493,287...48,509,050
|
|
G |
GRWD1 |
glutamate rich WD repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:107,814,402...107,821,107
Ensembl chr 1:107,815,063...107,820,858
|
|
G |
H1-10 |
H1.10 linker histone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:2,799,360...2,800,524
|
|
G |
H2BC4 |
H2B clustered histone 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr35:24,062,068...24,066,934
Ensembl chr35:24,066,399...24,066,779
|
|
G |
HAND2 |
heart and neural crest derivatives expressed 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr25:24,140,496...24,143,143
Ensembl chr25:24,141,243...24,152,958
|
|
G |
HBEGF |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21937979 |
|
NCBI chr 2:35,551,248...35,563,310
Ensembl chr 2:35,551,250...35,563,043
|
|
G |
HCN1 |
hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19747469 |
|
NCBI chr 4:64,777,069...65,162,603
Ensembl chr 4:64,775,577...65,160,444
|
|
G |
HELLS |
helicase, lymphoid specific |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr28:8,660,866...8,705,570
Ensembl chr28:8,661,008...8,705,580
|
|
G |
HEYL |
hes related family bHLH transcription factor with YRPW motif like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:3,242,738...3,257,275
Ensembl chr15:3,235,611...3,303,445
|
|
G |
HK1 |
hexokinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:20,396,761...20,516,889
Ensembl chr 4:20,421,526...20,518,211
|
|
G |
HK2 |
hexokinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:48,287,367...48,329,470
Ensembl chr17:48,289,272...48,348,663
|
|
G |
HMGB2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr25:23,939,024...23,941,720
Ensembl chr25:23,939,027...23,941,606
|
|
G |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr27:1,013,459...1,020,083
Ensembl chr27:1,015,868...1,019,891
|
|
G |
IDH2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27469509 |
|
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16845661 |
|
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27580383 PMID:28411859 |
|
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G |
IMPDH2 |
inosine monophosphate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:40,136,106...40,140,983
Ensembl chr20:40,136,154...40,140,972
|
|
G |
IPO4 |
importin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:4,171,525...4,180,666
Ensembl chr 8:4,171,527...4,181,151
|
|
G |
IPO5 |
importin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr22:48,126,053...48,182,897
Ensembl chr22:48,136,242...48,180,495
|
|
G |
IRAK4 |
interleukin 1 receptor associated kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28003376 |
|
NCBI chr27:10,313,782...10,340,652
Ensembl chr27:10,314,187...10,340,682
|
|
G |
KL |
klotho |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25550330 |
|
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
|
|
G |
KNG1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
|
|
G |
KPNA2 |
karyopherin subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:12,546,912...12,556,163
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26390243 PMID:27588471 PMID:33380422 |
|
NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
|
|
G |
LDHA |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr21:40,829,844...40,840,947
|
|
G |
LEF1 |
lymphoid enhancer binding factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr32:28,516,002...28,633,759
Ensembl chr32:28,517,108...28,634,019
|
|
G |
LMNB1 |
lamin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:15,996,627...16,052,719
Ensembl chr11:15,930,436...16,052,127
|
|
G |
LOC102155800 |
60S ribosomal protein L36a-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:52,628,292...52,628,713
|
|
G |
LOC487740 |
trifunctional purine biosynthetic protein adenosine-3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr31:29,032,399...29,063,706
|
|
G |
LOC609402 |
hemoglobin subunit beta-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23975182 PMID:29255069 |
|
NCBI chr21:28,187,535...28,188,991
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
|
|
G |
MAPT |
microtubule associated protein tau |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24556215 |
|
NCBI chr 9:9,572,174...9,674,082
Ensembl chr 9:9,570,557...9,674,349
|
|
G |
MECP2 |
methyl-CpG binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28592917 PMID:33010341 |
|
NCBI chr X:121,866,721...121,876,088
Ensembl chr X:121,873,218...121,932,994
|
|
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32045588 |
|
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
|
|
G |
MKI67IP |
MKI67 (FHA domain) interacting nucleolar phosphoprotein |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
|
|
G |
MRE11 |
MRE11 homolog, double strand break repair nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr21:6,448,909...6,528,185
Ensembl chr21:6,449,822...6,527,119
|
|
G |
MRPL12 |
mitochondrial ribosomal protein L12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:493,536...498,154
|
|
G |
MRPS5 |
mitochondrial ribosomal protein S5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:34,926,674...34,952,665
Ensembl chr17:34,926,743...34,952,473
|
|
G |
MYBPC3 |
myosin binding protein C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25566086 |
|
NCBI chr18:42,271,159...42,288,782
Ensembl chr18:42,271,724...42,289,215
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
|
|
G |
NAA10 |
N-alpha-acetyltransferase 10, NatA catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:121,777,658...121,782,097
Ensembl chr X:121,727,573...121,788,860
|
|
G |
NCL |
nucleolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr25:43,330,524...43,384,909
Ensembl chr25:43,330,799...43,384,258
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:27012417 PMID:29255069 |
|
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
|
|
G |
NOP56 |
NOP56 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr24:18,561,407...18,566,770
Ensembl chr24:18,561,408...18,566,719
|
|
G |
NOP58 |
NOP58 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr37:11,255,562...11,287,325
Ensembl chr37:11,255,589...11,287,279
|
|
G |
NPHP3 |
nephrocystin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12089381 |
|
NCBI chr23:29,662,486...29,703,629
Ensembl chr23:29,645,641...29,703,805
|
|
G |
NPM1 |
nucleophosmin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:40,756,464...40,770,174
Ensembl chr 4:40,756,465...40,770,175
|
|
G |
NPM3 |
nucleophosmin/nucleoplasmin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr28:14,373,446...14,375,624
Ensembl chr28:14,373,452...14,404,541
|
|
G |
NPPB |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 2:84,395,844...84,397,473
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29142166 PMID:32062620 |
|
NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
|
|
G |
NUDT21 |
nudix hydrolase 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:59,736,739...59,751,967
Ensembl chr 2:59,736,186...59,751,704
|
|
G |
NUS1 |
NUS1 dehydrodolichyl diphosphate synthase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33812996 |
|
NCBI chr 1:57,866,760...57,895,505
Ensembl chr 1:57,866,879...57,893,077
|
|
G |
P2RX7 |
purinergic receptor P2X 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27466191 |
|
NCBI chr26:7,928,863...7,983,956
Ensembl chr26:7,940,985...7,983,740
|
|
G |
PCBD1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:21,719,863...21,723,493
Ensembl chr 4:21,719,863...21,721,574
|
|
G |
PDE6B |
phosphodiesterase 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17213800 |
|
NCBI chr 3:91,746,571...91,775,372
Ensembl chr 3:91,746,571...91,775,372
|
|
G |
PIGN |
phosphatidylinositol glycan anchor biosynthesis class N |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:14,684,026...14,791,221
Ensembl chr 1:14,685,694...14,805,691
|
|
G |
PIM1 |
Pim-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25812446 |
|
NCBI chr12:6,213,504...6,217,933
Ensembl chr12:6,211,867...6,217,933
|
|
G |
PKD1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25877301 |
|
NCBI chr 6:38,811,051...38,865,503
Ensembl chr 6:38,837,964...38,865,503
|
|
G |
POLR1D |
RNA polymerase I and III subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr25:11,997,020...11,998,742
|
|
G |
PPAN |
peter pan homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:50,949,138...50,952,843
Ensembl chr20:50,949,138...50,952,843
|
|
G |
PRKCG |
protein kinase C gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 1:103,295,110...103,312,562
|
|
G |
PRKN |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15882845 |
|
NCBI chr 1:49,886,887...51,201,930
Ensembl chr 1:49,889,005...51,201,764
|
|
G |
PSAT1 |
phosphoserine aminotransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:80,376,469...80,408,177
Ensembl chr 1:80,377,115...80,408,162
|
|
G |
PSEN1 |
presenilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16651627 PMID:27567873 |
|
NCBI chr 8:46,495,551...46,569,532
Ensembl chr 8:46,495,624...46,569,532
|
|
G |
PTH |
parathyroid hormone |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30639440 |
|
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
|
|
G |
RANGRF |
RAN guanine nucleotide release factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:33,084,355...33,085,810
Ensembl chr 5:33,084,397...33,085,812
|
|
G |
RCL1 |
RNA terminal phosphate cyclase like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:93,144,164...93,204,233
Ensembl chr 1:93,142,635...93,435,997
|
|
G |
RFC4 |
replication factor C subunit 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr34:19,361,024...19,377,289
Ensembl chr34:19,361,044...19,377,294
|
|
G |
RHOA |
ras homolog family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25783350 |
|
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
|
|
G |
ROCK2 |
Rho associated coiled-coil containing protein kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr17:7,931,786...8,012,484
Ensembl chr17:7,934,739...8,178,707
|
|
G |
RPL10A |
ribosomal protein L10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:4,601,760...4,604,142
Ensembl chr12:4,601,766...4,604,220
|
|
G |
RPL13A |
ribosomal protein L13a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:107,010,190...107,014,267
Ensembl chr 1:107,010,190...107,014,267
|
|
G |
RPL27A |
ribosomal protein L27a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr21:32,099,792...32,102,761
Ensembl chr21:32,099,792...32,102,754
|
|
G |
RPSA |
ribosomal protein SA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr23:9,070,953...9,077,058
Ensembl chr23:9,070,953...9,077,057
|
|
G |
RRM1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr21:26,595,838...26,631,476
Ensembl chr21:26,595,914...26,631,135
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:7,106,515...7,113,868
Ensembl chr17:7,104,961...7,122,939
|
|
G |
RRS1 |
ribosome biogenesis regulator 1 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr29:16,016,134...16,018,046
Ensembl chr29:16,016,189...16,017,286
|
|
G |
S100A10 |
S100 calcium binding protein A10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21682946 |
|
NCBI chr17:60,984,138...60,994,915
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12888777 |
|
NCBI chr31:39,783,990...39,788,289
Ensembl chr31:39,784,506...39,788,183
|
|
G |
SATB1 |
SATB homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr23:24,614,198...24,692,254
Ensembl chr23:24,593,489...24,690,977
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
|
|
G |
SFXN1 |
sideroflexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:37,485,360...37,517,743
Ensembl chr 4:37,487,438...37,512,289
|
|
G |
SH3PXD2B |
SH3 and PX domains 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28719234 |
|
NCBI chr 4:39,854,213...39,950,704
Ensembl chr 4:39,854,211...39,949,958
|
|
G |
SHMT1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:41,221,531...41,248,653
Ensembl chr 5:41,221,562...41,253,166
|
|
G |
SLC15A2 |
solute carrier family 15 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr33:25,154,415...25,190,715
Ensembl chr33:25,154,448...25,189,929
|
|
G |
SLC19A1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr31:38,958,332...38,971,091
Ensembl chr31:38,967,013...38,971,094
|
|
G |
SLC29A1 |
solute carrier family 29 member 1 (Augustine blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27567601 |
|
NCBI chr12:12,632,233...12,644,669
Ensembl chr12:12,634,194...12,644,667
|
|
G |
SLC4A4 |
solute carrier family 4 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:60,375,215...60,670,664
Ensembl chr13:60,328,136...60,666,728
|
|
G |
SLC4A7 |
solute carrier family 4 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr23:16,710,649...16,788,277
Ensembl chr23:16,710,701...16,785,541
|
|
G |
SMARCC1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:41,165,593...41,337,237
Ensembl chr20:41,165,522...41,335,917
|
|
G |
SNCA |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892157 PMID:26075822 |
|
NCBI chr32:12,915,871...13,079,338
Ensembl chr32:12,916,215...13,060,383
|
|
G |
SNRPG |
small nuclear ribonucleoprotein polypeptide G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:68,826,250...68,836,755
Ensembl chr10:68,826,250...68,836,755 Ensembl chr10:68,826,250...68,836,755
|
|
G |
SOD1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12586733 PMID:12684256 PMID:19227972 PMID:20177826 PMID:21867702 PMID:23583883 PMID:24885036 PMID:28038988 PMID:28123103 PMID:29374221 PMID:29434186 More...
|
|
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
|
|
G |
SRM |
spermidine synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:84,968,833...84,973,111
Ensembl chr 2:84,967,570...84,973,087
|
|
G |
SRR |
serine racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25812446 |
|
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
|
|
G |
STK39 |
serine/threonine kinase 39 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr36:12,866,867...13,118,736
Ensembl chr36:12,867,188...13,183,160
|
|
G |
STRBP |
spermatid perinuclear RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:59,543,172...59,689,035
Ensembl chr 9:59,614,129...59,689,032
|
|
G |
SUCLG2 |
succinate-CoA ligase GDP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:23,915,149...24,167,740
Ensembl chr20:23,895,802...24,182,869
|
|
G |
TBX20 |
T-box transcription factor 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr14:46,891,706...46,946,899
Ensembl chr14:46,896,228...46,947,507
|
|
G |
TCF7L2 |
transcription factor 7 like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr28:23,966,079...24,162,775
Ensembl chr28:23,966,073...24,163,737
|
|
G |
TFAM |
transcription factor A, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28595911 |
|
NCBI chr 4:10,585,320...10,600,664
Ensembl chr 4:10,585,480...10,598,058
|
|
G |
TG |
thyroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30373627 |
|
NCBI chr13:29,350,726...29,597,908
Ensembl chr13:29,350,688...29,598,040
|
|
G |
TGFBR1 |
transforming growth factor beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27228633 |
|
NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594
|
|
G |
TIMM10 |
translocase of inner mitochondrial membrane 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:38,638,277...38,641,623
Ensembl chr18:38,638,696...38,641,623
|
|
G |
TIMM8A |
translocase of inner mitochondrial membrane 8A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:75,267,437...75,270,288
Ensembl chr X:75,267,450...75,270,288
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr X:41,201,623...41,205,314
Ensembl chr X:41,201,638...41,205,310
|
|
G |
TK1 |
thymidine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:2,959,450...2,970,908
Ensembl chr 9:2,959,488...2,971,064
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
TOMM40 |
translocase of outer mitochondrial membrane 40 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:110,530,233...110,541,049
Ensembl chr 1:110,530,597...110,541,042
|
|
G |
TOP2A |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:22,207,501...22,237,497
Ensembl chr 9:22,207,638...22,237,496
|
|
G |
TP53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23873029 |
|
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
|
|
G |
TPI1 |
triosephosphate isomerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr27:38,154,519...38,157,900
Ensembl chr27:38,154,519...38,158,137
|
|
G |
TTPA |
alpha tocopherol transfer protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11095717 PMID:11752462 |
|
NCBI chr29:13,177,690...13,198,910
Ensembl chr29:13,182,308...13,192,553
|
|
G |
TYMS |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:67,487,927...67,497,747
Ensembl chr 7:67,487,927...67,497,747
|
|
G |
UCK2 |
uridine-cytidine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr38:17,475,789...17,555,926
Ensembl chr38:17,479,558...17,579,675
|
|
G |
VCP |
valosin containing protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25884947 |
|
NCBI chr11:51,636,986...51,651,749
Ensembl chr11:51,637,411...51,651,714
|
|
G |
VIM |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16831193 |
|
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
|
|
G |
WNT11 |
Wnt family member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25783350 |
|
NCBI chr21:22,442,496...22,463,040
Ensembl chr21:22,446,051...22,463,173
|
|
G |
XRCC5 |
X-ray repair cross complementing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr37:23,095,769...23,185,680
Ensembl chr37:23,095,754...23,185,586
|
|
G |
XRCC6 |
X-ray repair cross complementing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:23,637,905...23,661,618
Ensembl chr10:23,638,237...23,661,480
|
|
|
G |
MAG |
myelin associated glycoprotein |
|
ISO |
protein:decreased expression:optic nerve |
RGD |
PMID:9820787 |
RGD:9685300 |
NCBI chr 1:117,288,306...117,301,975
Ensembl chr 1:117,288,343...117,302,386
|
|
G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
disease_progression |
ISO |
|
RGD |
PMID:26320658 |
RGD:11534569 |
NCBI chr15:4,972,369...4,984,218
Ensembl chr15:4,972,956...4,980,371
|
|
|
G |
ATP2A2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
treatment |
ISO |
|
RGD |
PMID:18416460 |
RGD:13782074 |
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
|
|
G |
BCL2L1 |
BCL2 like 1 |
|
ISO |
protein:increased expression:pancreas, mitochondrion (rat) |
RGD |
PMID:19331832 |
RGD:11353791 |
NCBI chr24:21,145,214...21,209,425
Ensembl chr24:21,145,215...21,196,355
|
|
G |
BECN1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:22850625 |
RGD:11560530 |
NCBI chr 9:20,204,203...20,215,081
Ensembl chr 9:20,204,220...20,214,236
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
|
ISO |
|
RGD |
PMID:10451498 |
RGD:10043817 |
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
|
|
G |
EDNRA |
endothelin receptor type A |
treatment |
ISO |
|
RGD |
PMID:12799311 |
RGD:1581841 |
NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463
|
|
G |
FAS |
Fas cell surface death receptor |
severity |
ISO |
protein:increased expression:Kupffer cell: |
RGD |
PMID:15797225 |
RGD:14700708 |
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
|
|
G |
FASLG |
Fas ligand |
severity |
ISO |
protein:increased expression:Kupffer cell: |
RGD |
PMID:15797225 |
RGD:14700708 |
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
|
|
G |
GSS |
glutathione synthetase |
|
ISO |
|
RGD |
PMID:17897920 |
RGD:11353819 |
NCBI chr24:23,973,807...24,000,281
Ensembl chr24:23,901,045...23,997,286
|
|
G |
HMGB1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:23706497 |
RGD:10402063 |
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
protein:increased expression:neutrophil: |
RGD |
PMID:26464680 |
RGD:11354914 |
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:10201790 PMID:23706497 |
RGD:10402063 RGD:11520782 |
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:25323753 |
RGD:11049477 |
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:24876883 |
RGD:10402805 |
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
|
|
G |
JAK1 |
Janus kinase 1 |
treatment |
ISO |
|
RGD |
PMID:21369693 |
RGD:19165136 |
NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
|
|
G |
KMO |
kynurenine 3-monooxygenase |
disease_progression |
ISO |
|
RGD |
PMID:26752518 PMID:28398044 |
RGD:11342439 RGD:13703053 |
NCBI chr 7:32,941,487...32,994,541
Ensembl chr 7:32,941,487...32,994,541
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
|
ISO |
|
RGD |
PMID:8913708 |
RGD:11062095 |
NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
|
|
G |
LAMP2 |
lysosomal associated membrane protein 2 |
|
ISO |
protein:decreased expression:pancreas |
RGD |
PMID:22850625 |
RGD:11560530 |
NCBI chr X:92,405,946...92,444,527
Ensembl chr X:92,407,950...92,444,765
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
treatment |
ISO |
|
RGD |
PMID:22850625 |
RGD:11560530 |
NCBI chr24:23,672,343...23,673,937
Ensembl chr24:23,633,579...23,673,921
|
|
G |
MIR155 |
microRNA mir-155 |
treatment |
ISO |
|
RGD |
PMID:29937734 PMID:30497068 |
RGD:21403683 RGD:21408596 |
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
|
RGD |
PMID:16127429 |
RGD:11075069 |
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
|
|
G |
PROC |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19680809 |
RGD:11100040 |
NCBI chr19:23,173,626...23,183,634
Ensembl chr19:23,173,635...23,183,563
|
|
G |
PROCR |
protein C receptor |
treatment |
ISO |
protein:increased expression:blood |
RGD |
PMID:24749346 PMID:25688263 |
RGD:13515127 RGD:13515128 |
NCBI chr24:24,184,063...24,188,452
Ensembl chr24:24,184,370...24,187,910
|
|
G |
PTAFR |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:21633536 |
RGD:9999225 |
NCBI chr 2:72,225,386...72,256,353
Ensembl chr 2:72,225,386...72,256,352
|
|
G |
SERPINC1 |
serpin family C member 1 |
treatment |
ISO |
|
RGD |
PMID:19546838 |
RGD:11035262 |
NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987
|
|
G |
SPINK1 |
serine peptidase inhibitor Kazal type 1 |
treatment |
ISO |
|
RGD |
PMID:15765407 |
RGD:10043090 |
NCBI chr 2:42,112,015...42,120,738
Ensembl chr 2:42,112,016...42,120,706
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
associated with Anemia, Hemolytic |
RGD |
PMID:12845374 PMID:15164724 |
RGD:10449461 RGD:1580295 |
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15164724 |
RGD:1580295 |
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15164724 |
RGD:1580295 |
NCBI chr 2:84,140,179...84,151,219
Ensembl chr 2:84,141,911...84,157,191
|
|
G |
VWF |
von Willebrand factor |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:17708840 |
RGD:11079229 |
NCBI chr27:38,834,812...38,972,614
Ensembl chr27:38,833,837...39,320,142
|
|
|
G |
RHOB |
ras homolog family member B |
|
ISO |
|
RGD |
PMID:1710770 |
RGD:704375 |
NCBI chr17:15,438,744...15,439,793
Ensembl chr17:15,439,143...15,441,136
|
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:16947020 |
RGD:7401280 |
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
|
|
G |
COQ7 |
coenzyme Q7, hydroxylase |
susceptibility |
ISO |
|
RGD |
PMID:23166727 |
RGD:10402105 |
NCBI chr 6:25,912,936...25,922,123
Ensembl chr 6:25,912,954...25,929,655
|
|
G |
CSF1R |
colony stimulating factor 1 receptor |
ameliorates |
ISO |
mouse cell line in a mouse model |
RGD |
PMID:20008303 |
RGD:150524291 |
NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510
|
|
G |
IL18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:16767432 |
RGD:8655941 |
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
|
|
G |
IL2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:9399664 |
RGD:8663451 |
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
|
RGD |
PMID:21278795 |
RGD:36049796 |
NCBI chr10:8,683,541...8,730,757
Ensembl chr10:8,684,242...8,729,268
|
|
G |
JAM3 |
junctional adhesion molecule 3 |
|
ISO |
|
RGD |
PMID:15994945 |
RGD:7488936 |
NCBI chr 5:1,082,619...1,165,188
Ensembl chr 5:1,084,560...1,165,121
|
|
G |
LECT2 |
leukocyte cell derived chemotaxin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30453282 |
|
NCBI chr11:23,864,062...23,873,720
Ensembl chr11:23,864,064...23,886,226
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
ameliorates |
ISO |
mouse cell line in a mouse model |
RGD |
PMID:29907597 |
RGD:151665504 |
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
treatment |
ISO |
mouse cell line in a mouse model |
RGD |
PMID:26111447 |
RGD:150521531 |
NCBI chr23:7,901,578...7,905,274
Ensembl chr23:7,901,250...7,904,534
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16565519 |
|
NCBI chr10:33,904,065...34,021,549
Ensembl chr10:33,886,343...34,021,696
|
|
|
G |
SERPINE1 |
serpin family E member 1 |
severity treatment |
ISO |
human gene in mouse model mRNA:increased expression:retina (mouse) |
RGD |
PMID:11292663 PMID:12766088 PMID:26610445 |
RGD:11073722 RGD:8547735 RGD:8547737 |
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
|
|
G |
SMO |
smoothened, frizzled class receptor |
treatment |
ISO |
|
RGD |
PMID:21063852 |
RGD:12859045 |
NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033
|
|
|
G |
B9D2 |
B9 domain containing 2 |
|
ISO |
|
RGD |
PMID:26645248 |
RGD:14995470 |
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
|
|
G |
CBS |
cystathionine beta-synthase |
|
ISO |
protein:increased expression:arcuate nucleus (rat) |
RGD |
PMID:27778022 |
RGD:38456012 |
NCBI chr31:37,230,900...37,247,170
|
|
G |
GLI1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:24782623 |
RGD:12879405 |
NCBI chr10:1,565,306...1,575,971
Ensembl chr10:1,565,244...1,575,982
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:22173919 |
RGD:10044253 |
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:22359633 |
RGD:11035224 |
NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
|
|
G |
PTCH1 |
patched 1 |
|
ISO |
|
RGD |
PMID:24782623 |
RGD:12879405 |
NCBI chr 1:71,246,750...71,309,036
Ensembl chr 1:71,238,195...71,305,662
|
|
G |
SMO |
smoothened, frizzled class receptor |
|
ISO |
|
RGD |
PMID:24782623 |
RGD:12879405 |
NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033
|
|
G |
SPINK1 |
serine peptidase inhibitor Kazal type 1 |
treatment |
ISO |
protein:increased secretion:pancreatic juice: |
RGD |
PMID:12123090 PMID:19904222 PMID:22173919 |
RGD:10043091 RGD:10044253 RGD:10044261 |
NCBI chr 2:42,112,015...42,120,738
Ensembl chr 2:42,112,016...42,120,706
|
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:12098510 |
RGD:8655962 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
NEFH |
neurofilament heavy chain |
|
ISO |
protein:decreased expression:spinal cord: |
RGD |
PMID:12742652 |
RGD:27226817 |
NCBI chr26:22,726,523...22,735,129
Ensembl chr26:22,726,526...22,735,125
|
|
G |
PLP1 |
proteolipid protein 1 |
|
ISO |
human sequence peptide in a mouse model; associated with Herpesviridae infections |
RGD |
PMID:12811845 |
RGD:30296670 |
NCBI chr X:77,191,112...77,207,772
Ensembl chr X:77,191,150...77,205,964
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
|
RGD |
PMID:17983428 |
RGD:13208507 |
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
|
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:19269163 |
RGD:11352683 |
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
|
|
G |
CD40LG |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:19269163 |
RGD:11352683 |
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
|
|
G |
CEACAM20 |
CEA cell adhesion molecule 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34605108 |
|
NCBI chr 1:110,744,921...110,829,413
Ensembl chr 1:110,805,089...110,827,606
|
|
|
G |
ACSL3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
|
RGD |
PMID:23526225 |
RGD:13831300 |
NCBI chr37:28,882,264...28,929,451
Ensembl chr37:28,864,147...28,938,866
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
|
|
G |
CD86 |
CD86 molecule |
treatment |
ISO |
|
RGD |
PMID:25344652 |
RGD:11354965 |
NCBI chr33:25,256,267...25,318,855
Ensembl chr33:25,256,267...25,318,087
|
|
G |
FAS |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
|
|
G |
FASLG |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
|
|
G |
IL23A |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:19935773 PMID:26344076 |
RGD:11251537 RGD:5037240 |
NCBI chr10:635,384...640,715
Ensembl chr10:638,719...640,359
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:intestinal mucosa (rat) mRNA:altered expression:liver |
CTD RGD |
PMID:17827786 PMID:19152228 |
RGD:11040994 RGD:2315573 |
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
|
ISO |
mRNA:decreased expression:kidney |
RGD |
PMID:22974786 |
RGD:11038789 |
NCBI chr 6:27,800,060...27,849,170
Ensembl chr 6:27,798,835...27,848,689
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 |
|
ISO |
mRNA:decreased expression:small intestine |
RGD |
PMID:19152228 |
RGD:2315573 |
NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
|
|
G |
ACAN |
aggrecan |
treatment |
ISO |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 3:51,995,100...52,031,812
Ensembl chr 3:51,969,779...52,031,544
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
|
RGD |
PMID:20213806 |
RGD:2325221 |
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
|
|
G |
ACSL1 |
acyl-CoA synthetase long chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr16:45,735,675...45,806,235
Ensembl chr16:45,735,703...45,804,970
|
|
G |
ACSL4 |
acyl-CoA synthetase long chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr X:82,864,506...82,943,984
Ensembl chr X:82,866,823...82,916,789
|
|
G |
ACSL5 |
acyl-CoA synthetase long chain family member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr28:23,437,838...23,478,763
Ensembl chr28:23,440,387...23,478,762
|
|
G |
ADAM10 |
ADAM metallopeptidase domain 10 |
|
ISO |
|
RGD |
PMID:23897050 |
RGD:13703039 |
NCBI chr30:23,605,724...23,732,038
Ensembl chr30:23,606,517...23,731,823
|
|
G |
ADAM17 |
ADAM metallopeptidase domain 17 |
|
ISO |
|
RGD |
PMID:23897050 |
RGD:13703039 |
NCBI chr17:6,589,874...6,638,788
Ensembl chr17:6,589,878...6,638,731
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19026984 PMID:21681567 PMID:23326410 |
RGD:5685385 RGD:5686814 |
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
|
|
G |
ADK |
adenosine kinase |
|
ISO |
|
RGD |
PMID:11160636 |
RGD:6482663 |
NCBI chr 4:24,540,626...25,047,032
Ensembl chr 4:24,540,659...25,046,464
|
|
G |
AHCY |
adenosylhomocysteinase |
|
ISO |
|
RGD |
PMID:11123369 |
RGD:1598898 |
NCBI chr24:23,410,553...23,423,494
Ensembl chr24:23,411,140...23,419,767
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194622 |
|
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:22391142 |
RGD:10041007 |
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
|
|
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
|
|
G |
ALOX15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:19675173 |
RGD:5509599 |
NCBI chr 5:31,883,544...31,891,357
Ensembl chr 5:31,882,501...32,038,119
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:10403283 PMID:23267026 |
RGD:2306928 RGD:7421573 |
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
|
|
G |
ANXA2 |
annexin A2 |
ameliorates |
ISO |
|
RGD |
PMID:24819400 |
RGD:150519886 |
NCBI chr30:25,176,845...25,210,244
Ensembl chr30:25,115,842...25,218,281
|
|
G |
AOC3 |
amine oxidase copper containing 3 |
|
ISO |
|
RGD |
PMID:16947396 |
RGD:2313925 |
NCBI chr 9:20,158,581...20,179,773
Ensembl chr 9:20,157,410...20,241,376
|
|
G |
APOA4 |
apolipoprotein A4 |
|
ISO |
protein:decreased expression:blood serum (rat) |
RGD |
PMID:10892728 |
RGD:5685694 |
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
|
|
G |
ARRB1 |
arrestin beta 1 |
|
ISO |
protein:increased expression:knee, synoviocyte (rat) |
RGD |
PMID:20965243 |
RGD:5509895 |
NCBI chr21:23,261,020...23,304,448
Ensembl chr21:23,235,711...23,297,786
|
|
G |
ARRB2 |
arrestin beta 2 |
|
ISO |
protein:increased expression:knee, synoviocyte (rat) |
RGD |
PMID:20965243 |
RGD:5509895 |
NCBI chr 5:31,831,208...31,838,875
Ensembl chr 5:31,829,864...31,839,454
|
|
G |
ATIC |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
ISO |
|
RGD |
PMID:17408934 |
RGD:5144054 |
NCBI chr37:22,420,645...22,446,769
Ensembl chr37:22,420,603...22,446,697
|
|
G |
B9D2 |
B9 domain containing 2 |
|
ISO |
|
RGD |
PMID:29763498 |
RGD:15036801 |
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:21199477 PMID:22978269 |
RGD:10054249 RGD:10054498 |
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:21199477 PMID:22978269 |
RGD:10054249 RGD:10054498 |
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:15001555 |
RGD:1625760 |
NCBI chr 8:65,017,655...65,028,899
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:21406003 |
RGD:6483549 |
NCBI chr 7:41,630,092...41,630,976
Ensembl chr 7:41,630,098...41,665,791
|
|
G |
BTK |
Bruton tyrosine kinase |
treatment |
ISO |
|
RGD |
PMID:22228807 PMID:32083858 |
RGD:11040701 RGD:151665122 |
NCBI chr X:75,270,952...75,302,663
Ensembl chr X:75,270,979...75,302,562
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:7347767 PMID:20051658 |
RGD:11041098 RGD:7411688 |
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:12355496 PMID:20975959 |
RGD:1600637 RGD:5130175 |
NCBI chr11:73,953,727...74,029,919
Ensembl chr11:73,953,727...74,029,851
|
|
G |
CABIN1 |
calcineurin binding protein 1 |
|
ISO |
|
RGD |
PMID:22275266 |
RGD:10054391 |
NCBI chr26:28,366,264...28,517,570
Ensembl chr26:28,366,265...28,517,656
|
|
G |
CAT |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22450443 |
|
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
|
|
G |
CBL |
Cbl proto-oncogene |
treatment |
ISO |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr 5:14,600,409...14,676,974
Ensembl chr 5:14,607,013...14,676,956
|
|
G |
CBLB |
Cbl proto-oncogene B |
|
ISO |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr33:11,255,453...11,665,755
Ensembl chr33:11,199,863...11,530,810
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
mRNA, protein:increased expression:synovium |
RGD |
PMID:17052673 PMID:18292571 PMID:18726678 PMID:24583103 |
RGD:11526142 RGD:2307008 RGD:2307052 RGD:2307143 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA, protein:increased expression:synovium, monocytes |
RGD |
PMID:9637726 PMID:17052673 |
RGD:2307143 RGD:4889940 |
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
onset |
ISO |
|
RGD |
PMID:17178563 |
RGD:6483780 |
NCBI chr 9:38,994,638...38,996,103
Ensembl chr 9:38,993,911...39,010,483
|
|
G |
CCN1 |
cellular communication network factor 1 |
ameliorates |
ISO |
|
RGD |
PMID:27653023 |
RGD:150429754 |
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
|
|
G |
CCR1 |
chemokine (C-C motif) receptor 1 |
|
ISO |
|
RGD |
PMID:14674010 PMID:18608173 |
RGD:1582346 RGD:5688144 |
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:16320322 |
RGD:4144893 |
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
treatment |
ISO |
mRNA:increased expression:ankle (rat) |
RGD |
PMID:14674010 PMID:22289897 |
RGD:1582346 RGD:5687744 |
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:18601859 |
RGD:2307202 |
NCBI chr37:12,503,849...12,536,362
Ensembl chr37:12,503,811...12,532,854
|
|
G |
CD4 |
CD4 molecule |
treatment |
ISO |
|
RGD |
PMID:12010568 PMID:15479897 |
RGD:10058957 RGD:10058960 |
NCBI chr27:38,204,003...38,250,771
Ensembl chr27:38,204,003...38,250,771
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20435931 |
RGD:5490544 |
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
|
|
G |
CD40LG |
CD40 ligand |
treatment |
ISO |
protein:increased expression:plasma (rat) |
RGD |
PMID:7689748 PMID:22611405 PMID:27218142 |
RGD:11344958 RGD:11352298 RGD:11352696 |
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
|
|
G |
CD44 |
CD44 molecule |
|
ISO |
protein:increased expression:joint, macrophage, lymphocyte |
RGD |
PMID:8639178 |
RGD:2289388 |
NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107
|
|
G |
CD59 |
CD59 molecule |
|
ISO |
|
RGD |
PMID:14519760 |
RGD:1600483 |
NCBI chr18:33,977,433...33,999,145
Ensembl chr18:33,977,480...33,998,329
|
|
G |
CD69 |
CD69 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12882836 |
|
NCBI chr27:36,197,202...36,205,045
Ensembl chr27:36,197,175...36,204,597
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:22004797 |
RGD:6902903 |
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
treatment |
ISO |
|
RGD |
PMID:10395320 |
RGD:8552686 |
NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
|
|
G |
CFH |
complement factor H |
|
ISO |
|
RGD |
PMID:19828624 |
RGD:5684557 |
NCBI chr38:2,878,677...2,956,226
|
|
G |
COL2A1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16200597 PMID:21188452 PMID:23326410 PMID:24709313 PMID:25194622 PMID:25481498 PMID:26070417 PMID:29908986 PMID:29935983 More...
|
|
NCBI chr27:6,756,994...6,787,733
Ensembl chr27:6,756,994...6,787,733
|
|
G |
CP |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19205849 PMID:19330884 |
RGD:2314686 |
NCBI chr23:43,969,297...44,033,226
Ensembl chr23:43,969,435...44,030,369
|
|
G |
CPOX |
coproporphyrinogen oxidase |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:9173682 |
RGD:1600958 |
NCBI chr33:5,446,022...5,459,152
Ensembl chr33:5,447,414...5,459,461
|
|
G |
CRHR1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:17550594 |
RGD:1626231 |
NCBI chr 9:9,708,696...9,763,281
Ensembl chr 9:9,714,204...9,763,402
|
|
G |
CRP |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19330884 |
|
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
|
|
G |
CRSP-3 |
calcitonin receptor-stimulating peptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16690336 |
|
NCBI chr21:37,676,841...37,680,643
Ensembl chr21:37,676,841...37,680,645
|
|
G |
CSF1 |
colony stimulating factor 1 |
|
ISO |
protein:increased expression:dorsal root ganglion |
RGD |
PMID:32510872 |
RGD:127338469 |
NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371
|
|
G |
CSF1R |
colony stimulating factor 1 receptor |
treatment |
ISO |
|
RGD |
PMID:18434589 |
RGD:151665814 |
NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510
|
|
G |
CSF3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:12742377 |
RGD:11039465 |
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
|
|
G |
CSK |
C-terminal Src kinase |
|
ISO |
|
RGD |
PMID:10411542 |
RGD:5134371 |
NCBI chr30:37,851,269...37,870,382
Ensembl chr30:37,852,046...37,870,378
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:7543497 PMID:22354915 |
RGD:7204500 RGD:7204519 |
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
|
|
G |
CTSB |
cathepsin B |
|
ISO |
mRNA:increased expression:knee joint, synovium (rat) |
RGD |
PMID:17195213 |
RGD:2315521 |
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
|
|
G |
CTSK |
cathepsin K |
|
ISO |
mRNA:increased expression:synovium, bone marrow |
RGD |
PMID:15353610 |
RGD:1601025 |
NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507
|
|
G |
CTSS |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:11465708 |
RGD:4892002 |
NCBI chr 2:59,022,794...59,032,095
Ensembl chr 2:59,022,794...59,032,095
|
|
G |
CX3CR1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:11465708 PMID:17123734 |
RGD:4891969 RGD:4892002 |
NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808
|
|
G |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
ameliorates |
ISO |
|
RGD |
PMID:24819400 |
RGD:150519886 |
NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275
|
|
G |
DHODH |
dihydroorotate dehydrogenase (quinone) |
|
ISO |
|
RGD |
PMID:15182735 |
RGD:2316231 |
NCBI chr 5:77,756,411...77,766,207
Ensembl chr 5:77,756,407...77,774,090
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194984 |
|
NCBI chr20:50,872,213...50,928,352
Ensembl chr20:50,879,527...50,928,029
|
|
G |
DRD1 |
dopamine receptor D1 |
treatment |
ISO |
mRNA:increased expression:corpus striatum (rat) |
RGD |
PMID:23762129 |
RGD:7248592 |
NCBI chr 4:37,550,454...37,554,641
Ensembl chr 4:37,549,708...37,553,287
|
|
G |
DRD2 |
dopamine receptor D2 |
treatment |
ISO |
mRNA:increased expression:corpus striatum (rat) |
RGD |
PMID:23762129 |
RGD:7248592 |
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
mRNA:increased expression:inguinal lymph node (mouse) |
RGD |
PMID:22249931 |
RGD:8661695 |
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
|
|
G |
EGFR |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7589090 |
|
NCBI chr18:5,983,669...6,044,092
Ensembl chr18:5,982,770...6,042,631
|
|
G |
ESR1 |
estrogen receptor 1 |
treatment |
ISO |
associated with Osteoporosis |
RGD |
PMID:20112355 |
RGD:10045851 |
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
|
|
G |
ESR2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:16269464 |
RGD:5508854 |
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
|
RGD |
PMID:21436072 |
RGD:5147764 |
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
|
|
G |
F2R |
coagulation factor II thrombin receptor |
severity |
ISO |
|
RGD |
PMID:19674841 |
RGD:7387269 |
NCBI chr 3:29,870,159...29,889,837
Ensembl chr 3:29,872,155...29,889,687
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:12511586 |
RGD:735010 |
NCBI chr 3:29,801,119...29,810,006
Ensembl chr 3:29,800,211...29,810,180
|
|
G |
FASLG |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:22354915 |
RGD:7204500 |
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
|
|
G |
FCGR1A |
Fc fragment of IgG receptor Ia |
|
ISO |
protein:increased expression:dorsal root ganglion CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12875993 PMID:16670289 PMID:32510872 |
RGD:127338469 RGD:9685708 |
NCBI chr17:59,073,139...59,102,023
Ensembl chr17:59,092,933...59,102,015
|
|
G |
FCGR2B |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:23341540 |
RGD:11344930 |
NCBI chr38:20,980,777...20,994,403
|
|
G |
FGF8 |
fibroblast growth factor 8 |
|
ISO |
|
RGD |
PMID:18699993 |
RGD:2314157 |
NCBI chr28:14,362,407...14,367,109
Ensembl chr28:14,362,109...14,367,468
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
|
ISO |
|
RGD |
PMID:22833219 |
RGD:10402072 |
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
|
RGD |
PMID:19180491 |
RGD:6483591 |
NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621
|
|
G |
FLT3 |
fms related receptor tyrosine kinase 3 |
|
ISO |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr25:11,551,372...11,670,891
Ensembl chr25:11,581,206...11,692,284
|
|
G |
FOXP3 |
forkhead box P3 |
treatment |
ISO |
mRNA,protein:decreased expression:lung |
RGD |
PMID:23643080 PMID:29264841 |
RGD:38549364 RGD:38599003 |
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
|
|
G |
GJA1 |
gap junction protein alpha 1 |
|
ISO |
|
RGD |
PMID:23165424 |
RGD:7207259 |
NCBI chr 1:60,941,772...60,944,694
Ensembl chr 1:60,929,097...60,942,936
|
|
G |
GLI1 |
GLI family zinc finger 1 |
treatment |
ISO |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr10:1,565,306...1,575,971
Ensembl chr10:1,565,244...1,575,982
|
|
G |
GPI |
glucose-6-phosphate isomerase |
|
ISO |
|
RGD |
PMID:23911657 |
RGD:11051957 |
NCBI chr 1:117,922,380...117,948,325
Ensembl chr 1:117,922,635...117,948,316
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
treatment disease_progression |
ISO |
protein:increased expression:aorta (rat) protein:altered expression:T cell (rat) |
RGD |
PMID:28349925 PMID:28631356 PMID:28653218 |
RGD:13513975 RGD:13513976 RGD:13513979 |
NCBI chr18:50,148,566...50,167,422
Ensembl chr18:50,148,598...50,167,428
|
|
G |
GRN |
granulin precursor |
|
ISO |
|
RGD |
PMID:21393509 |
RGD:5509782 |
NCBI chr 9:19,077,430...19,085,443
Ensembl chr 9:19,077,427...19,082,268
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16713974 |
|
NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
|
|
G |
GUSB |
glucuronidase beta |
treatment |
ISO |
|
RGD |
PMID:827200 |
RGD:42724460 |
NCBI chr 6:730,345...743,916
Ensembl chr 6:730,358...779,424
|
|
G |
HAVCR2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
mRNA,protein:altered expression:bone: |
RGD |
PMID:25264706 |
RGD:9686117 |
NCBI chr 4:53,018,990...53,032,035
Ensembl chr 4:53,012,234...53,033,393
|
|
G |
HDAC6 |
histone deacetylase 6 |
treatment |
ISO |
|
RGD |
PMID:23541634 |
RGD:9681550 |
NCBI chr X:42,004,268...42,024,726
Ensembl chr X:42,004,591...42,024,427
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:21679445 |
RGD:8693318 |
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
|
|
G |
HLA-DRB1 |
MHC class II DLA DRB1 beta chain |
|
ISO |
|
RGD |
PMID:19950279 PMID:21665435 |
RGD:5147558 RGD:5147586 |
NCBI chr12:2,151,409...2,164,564
|
|
G |
HMGB1 |
high mobility group box 1 |
|
ISO |
protein:altered localization:cytoplasm, extracellular matrix |
RGD |
PMID:12384917 |
RGD:728698 |
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:17119970 |
RGD:5508468 |
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
|
RGD |
PMID:10882416 PMID:15529360 |
RGD:12910542 RGD:1624244 |
NCBI chr37:7,010,421...7,025,912
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:7774621 PMID:12412757 PMID:19203382 PMID:22450443 |
RGD:10755750 RGD:2311498 |
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
|
|
G |
IGF1 |
insulin like growth factor 1 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:19246225 |
RGD:2306697 |
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
|
|
G |
IGFBP3 |
insulin like growth factor binding protein 3 |
|
ISO |
mRNA, protein:increased expression:kidney, serum |
RGD |
PMID:14642797 |
RGD:10402760 |
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
|
RGD |
PMID:19652024 PMID:21087862 |
RGD:7495772 RGD:7495778 |
NCBI chr16:23,359,551...23,419,114
Ensembl chr16:23,359,813...23,419,075
|
|
G |
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
ISO |
|
RGD |
PMID:16684367 |
RGD:12791276 |
NCBI chr X:122,232,052...122,253,499
Ensembl chr X:122,235,878...122,250,562
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic protein:decreased expression:serum: |
RGD CTD |
PMID:15270736 PMID:19169271 PMID:19193354 PMID:20974942 PMID:22052031 PMID:22450443 PMID:23140046 More...
|
RGD:1626677 RGD:2311059 RGD:7193038 RGD:7364838 RGD:8662976 |
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
IL13 |
interleukin 13 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:10444273 PMID:11860705 PMID:17665443 |
RGD:4889497 RGD:8549606 |
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:20188418 |
RGD:5000761 |
NCBI chr19:1,339,607...1,364,762
Ensembl chr19:1,339,967...1,364,762
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat) |
RGD CTD |
PMID:20925596 PMID:20974942 PMID:21194185 PMID:23377547 |
RGD:4781444 RGD:9068936 RGD:9130803 |
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
|
|
G |
IL18 |
interleukin 18 |
disease_progression |
ISO |
|
RGD |
PMID:15147345 PMID:19096963 |
RGD:4889415 RGD:4889503 |
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19169271 PMID:20379758 |
RGD:6907373 RGD:8662976 |
NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
|
|
G |
IL1B |
interleukin 1 beta |
treatment |
ISO |
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19330884 PMID:20131233 PMID:20974942 PMID:21557995 PMID:22450443 PMID:23140046 PMID:24028507 PMID:29408684 More...
|
RGD:10755447 RGD:13792834 RGD:7175317 RGD:7193038 |
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
treatment |
ISO |
mRNA:increased expression:popliteal lymph node (rat) rat model treated with human protein mouse model treated with human protein human gene in a rat model |
RGD |
PMID:10921508 PMID:12727108 PMID:15270736 PMID:22267332 PMID:23006786 |
RGD:1626677 RGD:6907376 RGD:8549801 RGD:8551741 RGD:8551745 |
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
|
|
G |
IL2 |
interleukin 2 |
treatment |
ISO |
protein:increased expression:serum: |
RGD |
PMID:2492102 PMID:19169271 |
RGD:10047055 RGD:8662976 |
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
|
|
G |
IL20 |
interleukin 20 |
|
ISO |
|
RGD |
PMID:20722035 |
RGD:5147393 |
NCBI chr 7:6,019,879...6,022,707
Ensembl chr 7:6,019,442...6,023,219
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17928458 |
RGD:2325988 |
NCBI chr 2:29,892,130...29,948,926
Ensembl chr 2:29,894,125...29,944,643
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:10444273 PMID:16869003 PMID:23140046 PMID:23972727 |
RGD:10402790 RGD:2317300 RGD:7193038 |
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
|
|
G |
IL6 |
interleukin 6 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:8607900 PMID:10381487 PMID:20131233 PMID:20974942 PMID:22450443 PMID:23503893 PMID:24028507 More...
|
RGD:10755447 RGD:11049551 RGD:11049553 RGD:11060267 |
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
|
|
G |
IL6ST |
interleukin 6 cytokine family signal transducer |
|
ISO |
|
RGD |
PMID:20626857 |
RGD:5509945 |
NCBI chr 2:43,214,050...43,273,014
Ensembl chr 2:43,214,050...43,248,124
|
|
G |
ITGA4 |
integrin subunit alpha 4 |
treatment |
ISO |
|
RGD |
PMID:12969328 |
RGD:9698440 |
NCBI chr36:24,670,464...24,686,719
Ensembl chr36:24,653,408...24,729,057
|
|
G |
ITGB2 |
integrin subunit beta 2 |
|
ISO |
|
RGD |
PMID:8881759 |
RGD:6482229 |
NCBI chr31:38,520,733...38,547,003
Ensembl chr31:38,521,103...38,547,018
|
|
G |
ITGB3 |
integrin subunit beta 3 |
|
ISO |
protein:increased expression:endothelial cell |
RGD |
PMID:16869003 |
RGD:2317300 |
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:19265135 |
RGD:6482234 |
NCBI chr24:11,656,926...11,693,146
Ensembl chr24:11,657,416...11,692,199
|
|
G |
JAK1 |
Janus kinase 1 |
treatment |
ISO |
|
RGD |
PMID:29452839 |
RGD:19165139 |
NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
|
|
G |
JAK2 |
Janus kinase 2 |
treatment |
ISO |
|
RGD |
PMID:22339472 PMID:22800927 PMID:23711144 |
RGD:10403066 RGD:10403074 RGD:10403081 |
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
|
|
G |
JAK3 |
Janus kinase 3 |
treatment |
ISO |
|
RGD |
PMID:18234077 PMID:21434883 PMID:25762693 |
RGD:11533938 RGD:11533942 RGD:11533944 |
NCBI chr20:45,051,135...45,068,445
Ensembl chr20:45,050,526...45,072,805
|
|
G |
KCNN4 |
potassium calcium-activated channel subfamily N member 4 |
ameliorates |
ISO |
|
RGD |
PMID:25131209 |
RGD:150521609 |
NCBI chr 1:111,391,464...111,407,612
Ensembl chr 1:111,391,159...111,407,701
|
|
G |
KLKB1 |
kallikrein B1 |
|
ISO |
|
RGD |
PMID:9783057 PMID:22739815 |
RGD:7297047 RGD:7327138 |
NCBI chr16:44,492,735...44,517,854
Ensembl chr16:44,469,632...44,540,292
|
|
G |
KNG1 |
kininogen 1 |
|
ISO |
peptidoglycan-polysaccharide-induced arthritis in Lewis rats |
RGD |
PMID:1996642 PMID:9214434 |
RGD:11059895 RGD:1600547 |
NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
|
|
G |
KYAT1 |
kynurenine aminotransferase 1 |
|
ISO |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr 9:54,760,212...54,796,996
Ensembl chr 9:54,760,276...54,796,848
|
|
G |
LEP |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15142272 |
|
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
|
|
G |
LGALS3 |
galectin 3 |
|
ISO |
|
RGD |
PMID:16507131 |
RGD:1625684 |
NCBI chr 8:30,977,438...30,994,711
Ensembl chr 8:30,983,633...30,994,705
|
|
G |
LOC403934 |
cell division cycle 42 |
|
ISO |
protein:increased activation:bone marrow, macrophage |
RGD |
PMID:21266780 |
RGD:5688271 |
NCBI chr 2:77,153,276...77,169,947
Ensembl chr 2:77,153,095...77,199,211
|
|
G |
LOC477699 |
alpha-2-macroglobulin |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:6163339 |
RGD:10046032 |
NCBI chr27:36,654,328...36,695,775
|
|
G |
LOC609365 |
CD46 molecule, complement regulatory protein-like |
|
ISO |
|
RGD |
PMID:21852528 |
RGD:6483461 |
NCBI chr 7:6,602,762...6,646,561
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
|
RGD |
PMID:16331767 |
RGD:10412332 |
NCBI chr 1:29,107,813...29,306,437
Ensembl chr 1:29,108,591...29,306,503
|
|
G |
MIF |
macrophage migration inhibitory factor |
|
ISO |
|
RGD |
PMID:10765927 |
RGD:1642012 |
|
|
G |
MIR152 |
microRNA mir-152 |
|
ISO |
CTD Direct Evidence: marker/mechanism miRNA:decreased exression:synovial membrane of synovial joint |
CTD RGD |
PMID:25194984 |
RGD:21066343 |
NCBI chr 9:24,335,161...24,335,219
Ensembl chr 9:24,335,146...24,335,225
|
|
G |
MIR26A-1 |
microRNA mir-26a-1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24423102 |
|
NCBI chr23:7,747,073...7,747,133
Ensembl chr23:7,747,064...7,747,140
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
|
ISO |
|
RGD |
PMID:21108488 PMID:21288455 PMID:24011916 |
RGD:7207362 RGD:7207365 RGD:8549748 |
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
treatment |
ISO |
|
RGD |
PMID:11435459 PMID:24244039 |
RGD:1582329 RGD:8694124 |
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
|
|
G |
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
treatment |
ISO |
mRNA:increased expression:ankle joint CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20703013 PMID:20974942 PMID:21679445 PMID:24011916 PMID:24244039 |
RGD:7241231 RGD:8549748 RGD:8693318 RGD:8694124 |
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:cartilage, serum, synovial fluid |
RGD |
PMID:17463159 |
RGD:1642035 |
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22450443 |
|
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
|
|
G |
MT-ATP8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
susceptibility |
ISO |
DNA:transversion: :m.7778G>T (mouse) |
RGD |
PMID:19759059 |
RGD:5490297 |
NCBI chr MT:7,803...8,006
Ensembl chr MT:7,803...8,006
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:22391142 |
RGD:10041007 |
NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
|
RGD |
PMID:20131263 |
RGD:8552884 |
NCBI chr23:7,901,578...7,905,274
Ensembl chr23:7,901,250...7,904,534
|
|
G |
MYOD1 |
myogenic differentiation 1 |
treatment |
ISO |
|
RGD |
PMID:23781298 |
RGD:9686078 |
NCBI chr21:40,257,792...40,260,461
Ensembl chr21:40,258,027...40,259,712
|
|
G |
MYOG |
myogenin |
treatment |
ISO |
|
RGD |
PMID:23781298 |
RGD:9686078 |
NCBI chr 7:112,116...114,604
Ensembl chr 7:112,034...113,892
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
severity |
ISO |
DNA:missense mutations:cds:p.M106V, p.M153T (rat) |
RGD |
PMID:12461526 |
RGD:628543 |
NCBI chr 6:5,702,222...5,719,515
Ensembl chr 6:5,605,694...5,719,458
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:20131263 PMID:21424514 |
RGD:5508728 RGD:8552884 |
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:ankle joint (mouse) |
RGD |
PMID:12826065 PMID:21880869 |
RGD:1358527 RGD:5509060 |
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
|
|
G |
NOS3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:29337196 |
RGD:13504725 |
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
|
|
G |
NPSR1 |
neuropeptide S receptor 1 |
treatment |
ISO |
|
RGD |
PMID:24884567 |
RGD:9831205 |
NCBI chr14:46,465,169...46,610,256
Ensembl chr14:46,466,544...46,609,477
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
severity |
ISO |
|
RGD |
PMID:16905546 |
RGD:11073695 |
NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
|
|
G |
NR1H2 |
nuclear receptor subfamily 1 group H member 2 |
|
ISO |
|
RGD |
PMID:21859686 |
RGD:6480864 |
NCBI chr 1:106,332,691...106,339,168
Ensembl chr 1:106,332,798...106,339,135
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
|
ISO |
|
RGD |
PMID:21859686 |
RGD:6480864 |
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
|
ISO |
|
RGD |
PMID:18706093 |
RGD:2300006 |
NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
|
|
G |
NTS |
neurotensin |
|
ISO |
|
RGD |
PMID:8518953 |
RGD:9743903 |
NCBI chr15:27,361,002...27,372,232
Ensembl chr15:27,361,002...27,372,232
|
|
G |
P2RY12 |
purinergic receptor P2Y12 |
|
ISO |
|
RGD |
PMID:22028806 |
RGD:6480518 |
NCBI chr23:45,908,574...45,954,675
Ensembl chr23:45,909,485...45,910,526
|
|
G |
PAM |
peptidylglycine alpha-amidating monooxygenase |
|
ISO |
|
RGD |
PMID:17138865 |
RGD:6483527 |
NCBI chr 3:8,141,508...8,312,081
Ensembl chr 3:8,142,061...8,290,477
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
severity |
ISO |
|
RGD |
PMID:16356201 |
RGD:5684009 |
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
severity |
ISO |
protein:increased expression:knee joint, blood vessels (mouse) |
RGD |
PMID:14613294 PMID:21982514 PMID:22548760 |
RGD:6484738 RGD:6771177 RGD:6771222 |
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
|
|
G |
PGF |
placental growth factor |
|
ISO |
|
RGD |
PMID:19180491 |
RGD:6483591 |
NCBI chr 8:48,059,554...48,110,534
Ensembl chr 8:48,059,552...48,075,170
|
|
G |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
|
ISO |
|
RGD |
PMID:18412166 |
RGD:6482696 |
NCBI chr 5:62,884,596...62,936,882
Ensembl chr 5:62,909,009...62,935,971
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:18412166 PMID:20374644 |
RGD:6482684 RGD:6482696 |
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
|
|
G |
PLAU |
plasminogen activator, urokinase |
|
ISO |
|
RGD |
PMID:20973954 |
RGD:6483801 |
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
|
|
G |
PTCH1 |
patched 1 |
treatment |
ISO |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 1:71,246,750...71,309,036
Ensembl chr 1:71,238,195...71,305,662
|
|
G |
PTGER4 |
prostaglandin E receptor 4 |
disease_progression treatment |
ISO |
mRNA:increased expression:tarsal joint, synovium (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11207665 PMID:18287210 PMID:20423341 |
RGD:10003041 RGD:10003052 RGD:10043377 |
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
|
|
G |
PTGES |
prostaglandin E synthase |
|
ISO |
mRNA, protein:increased expression:paw |
RGD |
PMID:12707354 |
RGD:2300108 |
NCBI chr 9:54,071,472...54,082,232
Ensembl chr 9:54,071,472...54,082,232
|
|
G |
PTGES3 |
prostaglandin E synthase 3 |
|
ISO |
mRNA:increased expression:paw (rat) |
RGD |
PMID:12707354 |
RGD:2300108 |
NCBI chr10:885,744...903,814
Ensembl chr10:870,392...909,161
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
mRNA, protein:increased expression:synovium |
RGD |
PMID:22289897 |
RGD:5687744 |
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
mRNA, protein:increased expression:synovium protein:increased expression:autopod joint |
RGD |
PMID:18758904 PMID:21765105 PMID:22289897 |
RGD:2300221 RGD:5508310 RGD:5687744 |
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
|
|
G |
PTPN22 |
protein tyrosine phosphatase non-receptor type 22 |
|
ISO |
protein:increased expression:metatarsophalangeal joint, mononuclear cell (rat) |
RGD |
PMID:24998229 |
RGD:11532752 |
NCBI chr17:51,623,628...51,683,039
Ensembl chr17:51,623,623...51,682,858
|
|
G |
RAG2 |
recombination activating 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20974942 |
|
NCBI chr18:31,614,143...31,621,489
Ensembl chr18:31,618,481...31,620,064
|
|
G |
S100A8 |
S100 calcium binding protein A8 |
|
ISO |
|
RGD |
PMID:8343166 |
RGD:633930 |
NCBI chr 7:43,540,667...43,541,604
Ensembl chr 7:43,501,989...43,541,604
|
|
G |
S100A9 |
S100 calcium binding protein A9 |
|
ISO |
|
RGD |
PMID:8343166 |
RGD:633930 |
NCBI chr 7:43,566,993...43,570,074
|
|
G |
SAA1 |
serum amyloid A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15944321 |
|
|
|
G |
SERPINC1 |
serpin family C member 1 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:22781611 |
RGD:11035273 |
NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987
|
|
G |
SFRP4 |
secreted frizzled related protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194984 |
|
NCBI chr18:12,018,049...12,028,123
Ensembl chr18:12,017,978...12,027,788
|
|
G |
SHH |
sonic hedgehog signaling molecule |
treatment |
ISO |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr16:18,650,553...18,663,571
Ensembl chr16:18,484,809...18,662,903
|
|
G |
SLC11A1 |
solute carrier family 11 member 1 |
severity |
ISO |
|
RGD |
PMID:17122779 |
RGD:5684943 |
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
|
|
G |
SLPI |
secretory leukocyte peptidase inhibitor |
treatment |
ISO |
protein:decreased expression:articular cartilage of joint |
RGD |
PMID:9744360 PMID:10449524 |
RGD:634208 RGD:9999431 |
NCBI chr24:32,566,030...32,568,406
Ensembl chr24:32,566,026...32,568,420
|
|
G |
SMO |
smoothened, frizzled class receptor |
treatment |
ISO |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
|
ISO |
mRNA:increased expression:mononuclear cell |
RGD |
PMID:16507131 |
RGD:1625684 |
NCBI chr 9:2,859,267...2,859,944
|
|
G |
SPN |
sialophorin |
|
ISO |
associated with Staphylococcal Infections |
RGD |
PMID:7927732 |
RGD:2303983 |
NCBI chr 6:17,770,303...17,774,946
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
ISO |
protein:increased tyrosine phosphorylation:macrophage, synovial cell CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14674010 PMID:15188379 |
RGD:1582346 |
NCBI chr37:1,513,438...1,549,837
Ensembl chr37:1,507,219...1,550,178
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15188379 PMID:21937456 PMID:23711144 |
RGD:10403081 |
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
|
|
G |
TAC1 |
tachykinin precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9259450 |
|
NCBI chr14:22,631,106...22,640,283
Ensembl chr14:22,632,642...22,640,258
|
|
G |
TGFBR2 |
transforming growth factor beta receptor 2 |
|
ISO |
protein:increased expression:synovium |
RGD |
PMID:9010265 |
RGD:1601623 |
NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
|
|
G |
THBD |
thrombomodulin |
|
ISO |
|
RGD |
PMID:16879225 |
RGD:5685015 |
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
|
|
G |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
|
ISO |
|
RGD |
PMID:12483743 |
RGD:2290463 |
NCBI chr20:6,399,522...6,405,089
Ensembl chr20:6,399,522...6,405,089
|
|
G |
TJP1 |
tight junction protein 1 |
|
ISO |
|
RGD |
PMID:18848892 |
RGD:2325138 |
NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:20131263 PMID:21725847 |
RGD:7241099 RGD:8552884 |
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
|
|
G |
TLR3 |
toll like receptor 3 |
|
ISO |
|
RGD |
PMID:20500834 |
RGD:5128706 |
NCBI chr16:44,617,012...44,633,591
Ensembl chr16:44,550,846...44,653,247
|
|
G |
TNF |
tumor necrosis factor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum: |
RGD CTD |
PMID:7589090 PMID:9598899 PMID:19169271 PMID:19203382 PMID:19330884 PMID:19765281 PMID:20131233 PMID:20974942 PMID:21452922 PMID:21690068 PMID:22450443 PMID:23052485 PMID:23140046 PMID:24028507 PMID:24394943 PMID:29408684 More...
|
RGD:10450611 RGD:10755447 RGD:13792834 RGD:7193038 RGD:7245941 RGD:8661761 RGD:8662976 |
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
treatment |
ISO |
CTD Direct Evidence: therapeutic Sinomenine CHEBI:9163 mRNA:decreased expression:bone |
CTD RGD |
PMID:16696922 PMID:23333834 PMID:24066131 |
RGD:1624171 RGD:42721982 |
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
treatment |
ISO |
|
RGD |
PMID:20370892 PMID:21690068 PMID:23052485 |
RGD:7245941 RGD:8661729 RGD:8661761 |
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
treatment |
ISO |
human protein in rat model |
RGD |
PMID:21463515 PMID:21690068 PMID:23052485 |
RGD:5131255 RGD:7245941 RGD:8661761 |
NCBI chr 2:84,140,179...84,151,219
Ensembl chr 2:84,141,911...84,157,191
|
|
G |
TRPV2 |
transient receptor potential cation channel subfamily V member 2 |
treatment |
ISO |
|
RGD |
PMID:25869297 |
RGD:9999444 |
NCBI chr 5:39,488,155...39,512,454
Ensembl chr 5:39,491,484...39,509,902
|
|
G |
TXNDC5 |
thioredoxin domain containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326410 |
|
NCBI chr35:7,834,135...7,854,836
Ensembl chr35:7,834,331...7,854,852
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9598899 PMID:26221077 |
|
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
|
|
G |
VIM |
vimentin |
|
ISO |
|
RGD |
PMID:7516431 |
RGD:6480480 |
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
|
|
G |
VIP |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:19055696 PMID:21998117 |
RGD:5685376 RGD:5685612 |
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
|
|
G |
XDH |
xanthine dehydrogenase |
|
ISO |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:25870945 |
RGD:13208957 |
NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
|
|
G |
XYLT1 |
xylosyltransferase 1 |
|
ISO |
mRNA:decreased expression:articular cartilage |
RGD |
PMID:19001053 |
RGD:2313142 |
NCBI chr 6:26,742,853...27,041,666
Ensembl chr 6:26,742,853...27,041,666
|
|
|
G |
ADAM17 |
ADAM metallopeptidase domain 17 |
|
ISO |
|
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chr17:6,589,874...6,638,788
Ensembl chr17:6,589,878...6,638,731
|
|
G |
ADAM8 |
ADAM metallopeptidase domain 8 |
|
ISO |
|
RGD |
PMID:9670863 |
RGD:2325244 |
NCBI chr28:40,853,665...40,865,604
Ensembl chr28:40,855,509...40,863,747
|
|
G |
AIF1 |
allograft inflammatory factor 1 |
|
ISO |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:19246105 |
RGD:2313022 |
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
|
|
G |
AKAP12 |
A-kinase anchoring protein 12 |
|
ISO |
mRNA,protein:increased expression:spinal cord |
RGD |
PMID:20155814 |
RGD:14348972 |
NCBI chr 1:41,614,893...41,712,350
Ensembl chr 1:41,614,714...41,709,798
|
|
G |
ALOX15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:15328042 |
RGD:5509618 |
NCBI chr 5:31,883,544...31,891,357
Ensembl chr 5:31,882,501...32,038,119
|
|
G |
AMIGO2 |
adhesion molecule with Ig like domain 2 |
severity |
ISO |
|
RGD |
PMID:28119027 |
RGD:14392778 |
NCBI chr27:7,507,426...7,510,015
Ensembl chr27:7,507,489...7,509,054
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
protein:increased expression:brain, astrocyte, macrophage |
RGD |
PMID:9472682 |
RGD:2306942 |
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
|
|
G |
APOE |
apolipoprotein E |
|
ISO |
|
RGD |
PMID:28578430 |
RGD:13703134 |
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
|
|
G |
AQP4 |
aquaporin 4 |
disease_progression severity |
ISO |
|
RGD |
PMID:19660138 PMID:21056916 PMID:21157915 PMID:23707078 |
RGD:5148015 RGD:5490116 RGD:5490117 RGD:8696030 |
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
|
|
G |
B2M |
beta-2-microglobulin |
|
ISO |
|
RGD |
PMID:15837577 |
RGD:6482690 |
NCBI chr30:11,331,574...11,337,991
Ensembl chr30:11,331,569...11,337,997
|
|
G |
B4GALT6 |
beta-1,4-galactosyltransferase 6 |
|
ISO |
mRNA:increased expression:astrocyte |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chr 7:57,849,872...57,917,289
Ensembl chr 7:57,849,884...57,914,360
|
|
G |
B9D2 |
B9 domain containing 2 |
|
ISO |
mRNA, protein:increased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
|
|
G |
BDNF |
brain derived neurotrophic factor |
|
ISO |
|
RGD |
PMID:23212569 |
RGD:10059360 |
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:22320401 |
RGD:7175513 |
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
|
|
G |
C6 |
complement C6 |
severity |
ISO |
|
RGD |
PMID:11970970 |
RGD:625607 |
NCBI chr 4:68,223,626...68,318,773
Ensembl chr 4:68,253,255...68,318,252
|
|
G |
CACNA1B |
calcium voltage-gated channel subunit alpha1 B |
|
ISO |
|
RGD |
PMID:11353727 |
RGD:1580151 |
NCBI chr 9:47,813,625...48,009,532
Ensembl chr 9:47,816,393...48,009,406
|
|
G |
CASP3 |
caspase 3 |
|
ISO |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
|
|
G |
CASP8 |
caspase 8 |
|
ISO |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
|
|
G |
CASP9 |
caspase 9 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
|
|
G |
CAV3 |
caveolin 3 |
onset |
ISO |
Protein:increased expression:spinal cord, astrocyte |
RGD |
PMID:15925413 |
RGD:1582168 |
NCBI chr20:9,384,901...9,398,055
Ensembl chr20:9,384,901...9,401,196
|
|
G |
CBLB |
Cbl proto-oncogene B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20453840 |
|
NCBI chr33:11,255,453...11,665,755
Ensembl chr33:11,199,863...11,530,810
|
|
G |
CCL1 |
C-C motif chemokine ligand 1 |
|
ISO |
mRNA:decreased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chr 9:38,931,895...38,936,969
Ensembl chr 9:38,933,514...38,961,187
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:spinal cord mRNA:decreased expression:lymph node mRNA:increased expression:optic chiasma (rat) |
RGD |
PMID:11241588 PMID:17666800 PMID:19865101 |
RGD:2307114 RGD:4145472 RGD:8548888 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased expression:brain (mouse) mRNA:increased expression:spinal cord |
RGD |
PMID:15833367 PMID:17666800 |
RGD:2307114 RGD:4890027 |
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
|
|
G |
CCR1 |
chemokine (C-C motif) receptor 1 |
|
ISO |
|
RGD |
PMID:14512166 PMID:14655765 |
RGD:5688165 RGD:5688167 |
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:spinal cord |
RGD |
PMID:9655467 |
RGD:632391 |
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15034073 |
RGD:6893394 |
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
mRNA:increased expression:spinal cord, macrophage, microglia (rat) |
RGD |
PMID:17484785 |
RGD:4890436 |
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:16061730 |
RGD:2307203 |
NCBI chr37:12,503,849...12,536,362
Ensembl chr37:12,503,811...12,532,854
|
|
G |
CD4 |
CD4 molecule |
treatment |
ISO |
protein:decreased expression:T lymphocyte: |
RGD |
PMID:3097071 PMID:9138014 |
RGD:10058963 RGD:10058968 |
NCBI chr27:38,204,003...38,250,771
Ensembl chr27:38,204,003...38,250,771
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
|
|
G |
CD86 |
CD86 molecule |
disease_progression resistance |
ISO |
protein:increased expression:spinal cord, blood vessel (rat) |
RGD |
PMID:10477557 PMID:20451260 |
RGD:4892207 RGD:4892227 |
NCBI chr33:25,256,267...25,318,855
Ensembl chr33:25,256,267...25,318,087
|
|
G |
CIITA |
class II major histocompatibility complex transactivator |
|
ISO |
|
RGD |
PMID:15821736 |
RGD:1358146 |
NCBI chr 6:31,774,486...31,837,025
Ensembl chr 6:31,774,609...31,836,820
|
|
G |
CNP |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
|
RGD |
PMID:7541143 PMID:10650887 PMID:21107918 |
RGD:6483335 RGD:6483351 RGD:6483353 |
NCBI chr 9:20,888,350...20,896,139
Ensembl chr 9:20,886,574...20,896,079
|
|
G |
COMT |
catechol-O-methyltransferase |
treatment |
ISO |
|
RGD |
PMID:25242632 |
RGD:13450949 |
NCBI chr26:29,359,930...29,381,854
Ensembl chr26:29,360,356...29,366,008
|
|
G |
CPB2 |
carboxypeptidase B2 |
|
ISO |
|
RGD |
PMID:22768796 |
RGD:7243111 |
NCBI chr22:5,074,805...5,126,635
Ensembl chr22:5,074,816...5,126,170
|
|
G |
CRSP-3 |
calcitonin receptor-stimulating peptide 3 |
no_association |
ISO |
|
RGD |
PMID:19563774 |
RGD:5684360 |
NCBI chr21:37,676,841...37,680,643
Ensembl chr21:37,676,841...37,680,645
|
|
G |
CSPG4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:20162860 PMID:21679768 |
RGD:5686852 RGD:5686863 |
NCBI chr30:38,465,486...38,498,365
Ensembl chr30:38,465,241...38,497,971
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
|
|
G |
CTSC |
cathepsin C |
|
ISO |
|
RGD |
PMID:843913 |
RGD:1599653 |
NCBI chr21:11,659,296...11,692,957
Ensembl chr21:11,659,292...11,692,816
|
|
G |
CTSS |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:16053521 |
RGD:4891973 |
NCBI chr 2:59,022,794...59,032,095
Ensembl chr 2:59,022,794...59,032,095
|
|
G |
CX3CR1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:16053521 PMID:24706865 |
RGD:4891973 RGD:9491767 |
NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19616545 |
RGD:7257694 |
NCBI chr37:24,831,351...24,846,387
Ensembl chr37:24,843,171...24,844,247
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:21038468 |
RGD:5135506 |
NCBI chr X:55,882,433...55,884,582
Ensembl chr X:55,882,433...55,884,582
|
|
G |
DAB2 |
DAB adaptor protein 2 |
disease_progression |
ISO |
|
RGD |
PMID:21890121 |
RGD:7243155 |
NCBI chr 4:69,625,874...69,648,349
Ensembl chr 4:69,625,527...69,648,321
|
|
G |
DLA-DRA |
MHC class II DR alpha chain |
|
ISO |
|
RGD |
PMID:8676084 |
RGD:5490166 |
NCBI chr12:2,133,026...2,137,825
Ensembl chr12:2,132,499...2,168,975
|
|
G |
DLK1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:24676147 |
RGD:150520045 |
NCBI chr 8:68,961,975...68,970,106
Ensembl chr 8:68,961,744...68,972,761
|
|
G |
DLL1 |
delta like canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chr12:72,265,078...72,272,347
Ensembl chr12:72,265,682...72,272,348
|
|
G |
DUSP10 |
dual specificity phosphatase 10 |
|
ISO |
|
RGD |
PMID:15306813 |
RGD:7775013 |
NCBI chr38:16,196,354...16,233,640
Ensembl chr38:16,196,635...16,231,315
|
|
G |
ENTPD1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
disease_progression |
ISO |
|
RGD |
PMID:19524108 |
RGD:9685491 |
NCBI chr28:9,181,851...9,311,835
Ensembl chr28:9,211,050...9,323,939
|
|
G |
EPO |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18382691 |
|
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr 9:11,930,614...12,006,724
Ensembl chr 9:11,934,965...12,006,814
|
|
G |
ESR2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:21182085 PMID:21565615 |
RGD:5508732 RGD:5508735 |
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
|
|
G |
FASLG |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:10944459 |
RGD:12903984 |
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
|
|
G |
FGF2 |
fibroblast growth factor 2 |
|
ISO |
mRNA:increased expression:spinal cord |
RGD |
PMID:8929896 PMID:9814819 |
RGD:8655647 RGD:9831448 |
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:18721816 |
RGD:10402153 |
NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621
|
|
G |
FOXO3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27742544 |
|
NCBI chr12:65,552,455...65,673,467
Ensembl chr12:65,552,310...65,670,198
|
|
G |
GHRH |
growth hormone releasing hormone |
resistance |
ISO |
|
RGD |
PMID:21846799 |
RGD:5687168 |
NCBI chr24:25,893,224...25,902,095
Ensembl chr24:25,893,225...25,897,712
|
|
G |
GHRL |
ghrelin and obestatin prepropeptide |
treatment |
ISO |
|
RGD |
PMID:19620309 |
RGD:12905041 |
NCBI chr20:8,092,921...8,097,512
Ensembl chr20:8,092,957...8,097,510
|
|
G |
GJC2 |
gap junction protein gamma 2 |
|
ISO |
protein:decreased expression:white matter of spinal cord, gap junction (mouse) |
RGD |
PMID:22461072 |
RGD:13208593 |
NCBI chr14:810,388...819,248
Ensembl chr14:810,386...820,420
|
|
G |
GLI1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:18991353 |
RGD:12801440 |
NCBI chr10:1,565,306...1,575,971
Ensembl chr10:1,565,244...1,575,982
|
|
G |
GLUD1 |
glutamate dehydrogenase 1 |
|
ISO |
mRNA, protein:decreased expression:spinal cord |
RGD |
PMID:9145307 |
RGD:6484657 |
NCBI chr 4:34,629,046...34,662,711
|
|
G |
HAVCR2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
mRNA:increased expression:spinal cord: |
RGD |
PMID:11823861 PMID:15913792 |
RGD:9686086 RGD:9686113 |
NCBI chr 4:53,018,990...53,032,035
Ensembl chr 4:53,012,234...53,033,393
|
|
G |
HLA-DRB1 |
MHC class II DLA DRB1 beta chain |
|
ISO |
|
RGD |
PMID:16194572 |
RGD:5147647 |
NCBI chr12:2,151,409...2,164,564
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:14691063 PMID:17085013 |
RGD:5508469 RGD:5508476 |
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
|
|
G |
IFNG |
interferon gamma |
treatment disease_progression |
ISO |
|
RGD |
PMID:15661899 PMID:22896638 |
RGD:10755692 RGD:7987912 |
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
|
|
G |
IGF1 |
insulin like growth factor 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7541143 |
RGD:6483353 |
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:23872438 |
RGD:7364993 |
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
IL10RA |
interleukin 10 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:12620647 |
RGD:2316323 |
NCBI chr 5:15,675,775...15,688,935
Ensembl chr 5:15,677,547...15,682,163
|
|
G |
IL12A |
interleukin 12A |
|
ISO |
|
RGD |
PMID:12471147 |
RGD:724447 |
NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
|
|
G |
IL12B |
interleukin 12B |
|
ISO |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:19233473 |
RGD:4831840 |
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
|
|
G |
IL13 |
interleukin 13 |
severity |
ISO |
|
RGD |
PMID:7523520 PMID:18250480 |
RGD:5684366 RGD:5684367 |
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
|
|
G |
IL16 |
interleukin 16 |
|
ISO |
|
RGD |
PMID:17641011 |
RGD:5024940 |
NCBI chr 3:56,473,485...56,575,504
Ensembl chr 3:56,473,486...56,575,104
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:16200068 PMID:16785554 PMID:19233473 PMID:20003332 |
RGD:4831840 RGD:4888522 RGD:4889113 RGD:9212317 |
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
mRNA:increased expression:spinal cord |
RGD |
PMID:9834127 PMID:9846824 |
RGD:4889542 RGD:4889543 |
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
|
|
G |
IL18R1 |
interleukin 18 receptor 1 |
|
ISO |
mRNA:increased expression:lymph node |
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr10:40,614,336...40,653,300
Ensembl chr10:40,615,312...40,653,454
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7593560 |
RGD:8551836 |
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
|
|
G |
IL21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:18997868 |
RGD:5147399 |
NCBI chr19:17,641,833...17,651,275
Ensembl chr19:17,641,833...17,651,266
|
|
G |
IL21R |
interleukin 21 receptor |
disease_progression no_association |
ISO |
|
RGD |
PMID:18353312 PMID:18546146 |
RGD:6892939 RGD:6892940 |
NCBI chr 6:19,181,846...19,217,915
Ensembl chr 6:19,182,071...19,217,931
|
|
G |
IL22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr10:10,487,367...10,492,238
Ensembl chr10:10,487,262...10,492,371
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
protein:decreased expression:blood serum (mouse) |
RGD |
PMID:33403844 |
RGD:126790527 |
NCBI chr 6:18,243,988...18,248,369
Ensembl chr 6:18,244,040...18,247,635
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chr 2:29,892,130...29,948,926
Ensembl chr 2:29,894,125...29,944,643
|
|
G |
IL32 |
interleukin 32 |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:26564962 |
RGD:150340739 |
NCBI chr 6:38,119,287...38,122,979
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:1383385 PMID:18239607 |
RGD:7829778 RGD:8142395 |
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
protein:increased expression:oligodendrocytes (rat) |
RGD |
PMID:9358769 PMID:23322593 |
RGD:12791289 RGD:2307412 |
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
|
|
G |
ITGA4 |
integrin subunit alpha 4 |
susceptibility treatment |
ISO |
rat bone marrow cells in a mouse model |
RGD |
PMID:12626659 PMID:18722022 |
RGD:9698418 RGD:9698436 |
NCBI chr36:24,670,464...24,686,719
Ensembl chr36:24,653,408...24,729,057
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chr24:11,656,926...11,693,146
Ensembl chr24:11,657,416...11,692,199
|
|
G |
JAK2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
|
|
G |
JAK3 |
Janus kinase 3 |
treatment |
ISO |
|
RGD |
PMID:25012120 |
RGD:11533939 |
NCBI chr20:45,051,135...45,068,445
Ensembl chr20:45,050,526...45,072,805
|
|
G |
KDR |
kinase insert domain receptor |
|
ISO |
|
RGD |
PMID:19233483 |
RGD:5684404 |
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
|
|
G |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:25972476 |
RGD:12910744 |
NCBI chr13:47,108,442...47,190,935
Ensembl chr13:47,108,504...47,190,029
|
|
G |
LOC100686073 |
metallothionein-1 |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr 2:59,603,021...59,604,173
Ensembl chr 2:59,603,014...59,604,132
|
|
G |
LOC477699 |
alpha-2-macroglobulin |
treatment |
ISO |
|
RGD |
PMID:1710603 |
RGD:10046021 |
NCBI chr27:36,654,328...36,695,775
|
|
G |
LOC491316 |
midkine |
|
ISO |
|
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chr 9:55,100,491...55,101,081
|
|
G |
LOC607986 |
myelin associated oligodendrocyte basic protein |
|
ISO |
|
RGD |
PMID:10623862 |
RGD:27226694 |
NCBI chr23:9,121,277...9,176,128
Ensembl chr23:9,121,319...9,161,972
|
|
G |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
protein:increased expression:cerebellum, spinal cord |
RGD |
PMID:19299462 |
RGD:13800552 |
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
|
|
G |
LTA |
lymphotoxin alpha |
|
ISO |
mRNA:increased expression:brain mRNA:increased expression:spinal cord |
RGD |
PMID:7593556 PMID:9184655 |
RGD:1625038 RGD:4143220 |
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
|
|
G |
MAPT |
microtubule associated protein tau |
treatment |
ISO |
|
RGD |
PMID:15494405 |
RGD:1358431 |
NCBI chr 9:9,572,174...9,674,082
Ensembl chr 9:9,570,557...9,674,349
|
|
G |
MBP |
myelin basic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism human sequence peptide in a rat model; associated with Herpesviridae infections |
CTD RGD |
PMID:11501064 PMID:12811845 PMID:15159442 PMID:16285900 PMID:17884951 PMID:24070732 More...
|
RGD:30296670 RGD:7349334 |
NCBI chr 1:2,841,801...2,952,553
Ensembl chr 1:2,846,589...2,951,860
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
ISO |
|
RGD |
PMID:19922364 |
RGD:2325703 |
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
|
ISO |
|
RGD |
PMID:9549496 |
RGD:8547909 |
NCBI chr 5:29,187,902...29,196,157
Ensembl chr 5:29,187,851...29,196,153
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
treatment |
ISO |
protein:increased expression:multiple tissues |
RGD |
PMID:9549496 PMID:20810258 PMID:22800566 PMID:24797785 |
RGD:13204762 RGD:13204801 RGD:8547909 RGD:8547936 |
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
|
|
G |
MOG |
myelin oligodendrocyte glycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10384097 PMID:12799014 PMID:12904460 PMID:14624757 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 More...
|
RGD:9685372 RGD:9685373 RGD:9685375 |
NCBI chr35:26,256,311...26,267,357
Ensembl chr35:26,256,489...26,266,832
|
|
G |
MT-III |
transcription initiation factor TFIID subunit 4 |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr 2:59,624,845...59,630,386
|
|
G |
MT2A |
metallothionein 1H |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chr 2:59,607,926...59,608,825
Ensembl chr 2:59,607,927...59,626,727
|
|
G |
NCAM1 |
neural cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:hippocampus |
RGD |
PMID:17064783 |
RGD:40924670 |
NCBI chr 5:19,895,587...20,192,334
Ensembl chr 5:19,895,613...20,191,995
|
|
G |
NEFL |
neurofilament light chain |
|
ISO |
protein:increased expression:cerebrospinal fluid, spinal cord |
RGD |
PMID:16182933 |
RGD:2299007 |
NCBI chr25:32,463,361...32,468,965
Ensembl chr25:32,463,452...32,467,224
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19910389 |
|
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
|
|
G |
NGF |
nerve growth factor |
|
ISO |
protein, mRNA:increased expression:thalamus and cortex, CNS |
RGD |
PMID:8866783 |
RGD:5508386 |
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
|
|
G |
NGFR |
nerve growth factor receptor |
severity |
ISO |
mRNA:increased expression:central nervous system |
RGD |
PMID:8866783 PMID:16519950 |
RGD:5508312 RGD:5508386 |
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:21857957 |
RGD:5509069 |
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
|
|
G |
NR1H2 |
nuclear receptor subfamily 1 group H member 2 |
|
ISO |
|
RGD |
PMID:21266776 |
RGD:6480877 |
NCBI chr 1:106,332,691...106,339,168
Ensembl chr 1:106,332,798...106,339,135
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
|
RGD |
PMID:17322387 |
RGD:4892331 |
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
|
|
G |
NTRK1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:brain subventricular zone: |
RGD |
PMID:15589512 |
RGD:5684777 |
NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
|
|
G |
OLIG1 |
oligodendrocyte transcription factor 1 |
treatment |
ISO |
|
RGD |
PMID:24941845 |
RGD:40902822 |
NCBI chr31:27,718,925...27,721,301
Ensembl chr31:27,719,026...27,719,862
|
|
G |
OLIG2 |
oligodendrocyte transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:24941845 PMID:29682587 |
RGD:40902822 RGD:40902863 |
NCBI chr31:27,674,112...27,677,521
Ensembl chr31:27,674,107...27,676,822
|
|
G |
PDCD1 |
programmed cell death 1 |
susceptibility |
ISO |
|
RGD |
PMID:24648472 |
RGD:40818258 |
NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
|
|
G |
PDGFB |
platelet derived growth factor subunit B |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr10:25,798,877...25,819,422
Ensembl chr10:25,798,938...25,817,746
|
|
G |
PDGFRA |
platelet derived growth factor receptor alpha |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr13:46,729,722...46,775,828
Ensembl chr13:46,730,703...46,773,278
|
|
G |
PDGFRB |
platelet derived growth factor receptor beta |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chr 4:58,925,922...58,963,639
Ensembl chr 4:58,926,351...58,962,283
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:20303183 |
RGD:6482686 |
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
|
|
G |
PLP1 |
proteolipid protein 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21068375 PMID:24941845 |
RGD:40902822 |
NCBI chr X:77,191,112...77,207,772
Ensembl chr X:77,191,150...77,205,964
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17261635 |
|
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
|
|
G |
PRF1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:20708278 |
RGD:6482806 |
NCBI chr 4:21,497,865...21,502,429
Ensembl chr 4:21,498,249...21,500,864
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
severity |
ISO |
|
RGD |
PMID:19486896 |
RGD:6484540 |
NCBI chr 4:68,579,061...68,614,548
Ensembl chr 4:68,579,037...68,611,841
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:microglia, macrophage, |
RGD |
PMID:10229132 PMID:21667309 |
RGD:5688149 RGD:5688250 |
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:endothelial cell |
RGD |
PMID:10229132 PMID:21667309 |
RGD:5688149 RGD:5688250 |
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
|
|
G |
PTN |
pleiotrophin |
|
ISO |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chr16:11,283,078...11,382,820
Ensembl chr16:11,283,077...11,382,814
|
|
G |
QKI |
QKI, KH domain containing RNA binding |
|
ISO |
|
RGD |
PMID:22740327 |
RGD:10045997 |
NCBI chr 1:51,800,294...51,956,891
Ensembl chr 1:51,800,309...51,952,714
|
|
G |
RANGRF |
RAN guanine nucleotide release factor |
|
ISO |
|
RGD |
PMID:8557821 |
RGD:6771380 |
NCBI chr 5:33,084,355...33,085,810
Ensembl chr 5:33,084,397...33,085,812
|
|
G |
RHOA |
ras homolog family member A |
severity |
ISO |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17983427 |
RGD:2298887 |
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte: |
RGD |
PMID:11733372 |
RGD:13208549 |
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
|
|
G |
SHH |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:15892298 PMID:18991353 |
RGD:12801423 RGD:12801440 |
NCBI chr16:18,650,553...18,663,571
Ensembl chr16:18,484,809...18,662,903
|
|
G |
SIGMAR1 |
sigma non-opioid intracellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr11:51,310,672...51,313,426
Ensembl chr11:51,311,085...51,313,400
|
|
G |
SIRT1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23547115 |
|
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
|
|
G |
SLPI |
secretory leukocyte peptidase inhibitor |
treatment |
ISO |
|
RGD |
PMID:22436018 |
RGD:9999395 |
NCBI chr24:32,566,030...32,568,406
Ensembl chr24:32,566,026...32,568,420
|
|
G |
SNCB |
synuclein beta |
|
ISO |
|
RGD |
PMID:12496452 |
RGD:730073 |
NCBI chr 4:36,710,236...36,719,455
Ensembl chr 4:36,616,039...36,764,501
|
|
G |
SRSF9 |
serine and arginine rich splicing factor 9 |
treatment |
ISO |
|
RGD |
PMID:20616573 |
RGD:11040805 |
NCBI chr26:16,363,275...16,369,699
Ensembl chr26:16,363,475...16,369,666
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chr37:1,513,438...1,549,837
Ensembl chr37:1,507,219...1,550,178
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:17878325 PMID:22066025 |
RGD:6483041 RGD:6892946 |
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
|
ISO |
mRNA, protein:decreased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chr38:13,430,832...13,511,655
Ensembl chr38:13,429,148...13,510,242
|
|
G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chr10:30,627,154...30,681,520
Ensembl chr10:30,627,154...30,694,288
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 |
RGD:2312575 |
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 |
RGD:2312575 |
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
|
|
G |
TNF |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:11421579 |
RGD:12904661 |
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:12196270 |
RGD:1580348 |
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
|
|
G |
VDR |
vitamin D receptor |
treatment |
ISO |
|
RGD |
PMID:21287548 PMID:21318047 |
RGD:13210791 RGD:8158064 |
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
mRNA:decreased expression:Cerebrospinal Fluid: mRNA,protein:decreased expression:spinal cord: |
RGD |
PMID:12387457 PMID:17083617 |
RGD:634258 RGD:7421596 |
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
|
|
G |
VIP |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:20978211 |
RGD:5685386 |
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
|
|
G |
XBP1 |
X-box binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr26:22,162,675...22,168,149
Ensembl chr26:22,163,222...22,168,105
|
|
|
G |
ARPC5 |
actin related protein 2/3 complex subunit 5 |
treatment |
ISO |
|
RGD |
PMID:17997938 |
RGD:11049469 |
NCBI chr 7:16,976,392...16,986,015
Ensembl chr 7:16,977,555...16,985,943
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:147324 PMID:17962462 |
RGD:11040804 RGD:7401263 |
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
|
|
G |
C6 |
complement C6 |
susceptibility |
ISO |
|
RGD |
PMID:17034580 |
RGD:1600670 |
NCBI chr 4:68,223,626...68,318,773
Ensembl chr 4:68,253,255...68,318,252
|
|
G |
CD40LG |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:11359850 |
RGD:8547800 |
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
|
|
G |
CFB |
complement factor B |
treatment |
ISO |
|
RGD |
PMID:25355917 |
RGD:11041161 |
NCBI chr12:1,400,143...1,406,267
|
|
G |
CHRNA1 |
cholinergic receptor nicotinic alpha 1 subunit |
treatment |
ISO |
|
RGD |
PMID:10606626 |
RGD:704386 |
NCBI chr36:18,726,243...18,742,505
Ensembl chr36:18,726,243...18,742,505
|
|
G |
CTSL3 |
cathepsin L family member 3 |
|
ISO |
mRNA:increased expression:quadriceps (rat) |
RGD |
PMID:16365386 |
RGD:2315588 |
NCBI chr 1:72,215,774...72,219,093
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:15843529 PMID:19232748 |
RGD:1598501 RGD:2311364 |
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15843529 PMID:19232748 |
RGD:1598501 RGD:2311364 |
NCBI chr X:55,882,433...55,884,582
Ensembl chr X:55,882,433...55,884,582
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:11585642 |
RGD:1626617 |
NCBI chr19:1,339,607...1,364,762
Ensembl chr19:1,339,967...1,364,762
|
|
G |
IL23R |
interleukin 23 receptor |
|
ISO |
mRNA:increased expression:lymph node |
RGD |
PMID:21193288 |
RGD:5108250 |
NCBI chr 5:43,307,422...43,369,806
Ensembl chr 5:43,308,982...43,368,474
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:18250419 |
RGD:2325986 |
NCBI chr 2:29,892,130...29,948,926
Ensembl chr 2:29,894,125...29,944,643
|
|
G |
IL4R |
interleukin 4 receptor |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:19395316 |
RGD:4889981 |
NCBI chr 6:19,254,183...19,280,973
Ensembl chr 6:19,254,487...19,389,291
|
|
G |
MUSK |
muscle associated receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:17081697 |
RGD:2317084 |
NCBI chr11:65,552,320...65,642,165
Ensembl chr11:65,551,889...65,642,349
|
|
G |
MYOG |
myogenin |
|
ISO |
|
RGD |
PMID:1312030 |
RGD:9686077 |
NCBI chr 7:112,116...114,604
Ensembl chr 7:112,034...113,892
|
|
G |
RAPSN |
receptor associated protein of the synapse |
|
ISO |
protein:decreased expression:neuromuscular junction |
RGD |
PMID:19344765 |
RGD:8549750 |
NCBI chr18:42,199,160...42,210,668
Ensembl chr18:42,199,412...42,210,673
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
ISO |
|
RGD |
PMID:23674516 |
RGD:8695925 |
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
protein:increased expression:heart |
RGD |
PMID:24599045 |
RGD:8696002 |
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
|
|
G |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:23833961 PMID:28903333 |
RGD:13702869 RGD:13702874 |
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
|
|
G |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:23833961 |
RGD:13702874 |
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
|
|
G |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:23833961 |
RGD:13702874 |
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
|
|
G |
CAV1 |
caveolin 1 |
|
ISO |
|
RGD |
PMID:17060028 |
RGD:1625364 |
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
|
|
G |
CAV2 |
caveolin 2 |
|
ISO |
|
RGD |
PMID:17060028 |
RGD:1625364 |
NCBI chr14:55,437,622...55,445,481
Ensembl chr14:55,437,622...55,445,469
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
disease_progression |
ISO |
mRNA, protein:increased expression:heart, serum (rat) |
RGD |
PMID:11472393 |
RGD:8549580 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
CD28 |
CD28 molecule |
severity treatment |
ISO |
|
RGD |
PMID:8759765 PMID:19907173 |
RGD:13702882 RGD:13702883 |
NCBI chr37:12,503,849...12,536,362
Ensembl chr37:12,503,811...12,532,854
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:25297507 |
RGD:13702884 |
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
|
|
G |
FGL2 |
fibrinogen like 2 |
severity |
ISO |
|
RGD |
PMID:28892130 |
RGD:38549573 |
NCBI chr18:17,328,794...17,335,429
Ensembl chr18:17,331,780...17,335,401
|
|
G |
FOXP3 |
forkhead box P3 |
severity treatment |
ISO |
|
RGD |
PMID:19907173 PMID:28892130 |
RGD:13702882 RGD:38549573 |
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
treatment |
ISO |
|
RGD |
PMID:30024944 |
RGD:13792695 |
NCBI chr18:50,148,566...50,167,422
Ensembl chr18:50,148,598...50,167,428
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:19615879 |
RGD:11041636 |
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
|
|
G |
HMGB1 |
high mobility group box 1 |
|
ISO |
protein:increased expression:heart, serum |
RGD |
PMID:24599045 |
RGD:8696002 |
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
treatment |
ISO |
|
RGD |
PMID:21927577 |
RGD:5685668 |
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:11701617 |
RGD:13702911 |
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:19907173 |
RGD:13702882 |
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
IL13 |
interleukin 13 |
treatment |
ISO |
|
RGD |
PMID:15902684 |
RGD:8549607 |
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
treatment |
ISO |
mouse gene in a rat model |
RGD |
PMID:15795329 |
RGD:8551728 |
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
|
|
G |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:26339812 |
RGD:11062109 |
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
|
|
G |
KCNA5 |
potassium voltage-gated channel subfamily A member 5 |
|
ISO |
|
RGD |
PMID:15306225 |
RGD:7242784 |
NCBI chr27:39,808,987...39,810,789
Ensembl chr27:39,756,363...39,811,035
|
|
G |
MYH6 |
myosin heavy chain 6 |
|
ISO |
|
RGD |
PMID:10199887 |
RGD:12792956 |
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
|
ISO |
protein:increased expression:myocardium (rat) |
RGD |
PMID:15167281 |
RGD:8553039 |
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
|
|
G |
RORC |
RAR related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:28892130 |
RGD:38549573 |
NCBI chr17:60,821,498...60,842,485
Ensembl chr17:60,821,981...60,842,453
|
|
G |
RPS6 |
ribosomal protein S6 |
|
ISO |
|
RGD |
PMID:22014063 |
RGD:11041642 |
NCBI chr11:39,161,422...39,165,148
Ensembl chr11:39,161,422...39,165,148
|
|
G |
SIRT1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:17322642 |
RGD:9586020 |
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
|
|
|
G |
ADAM8 |
ADAM metallopeptidase domain 8 |
|
ISO |
|
RGD |
PMID:9670863 |
RGD:2325244 |
NCBI chr28:40,853,665...40,865,604
Ensembl chr28:40,855,509...40,863,747
|
|
G |
AIF1 |
allograft inflammatory factor 1 |
|
ISO |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:15710454 |
RGD:2313042 |
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
protein:increased expression:sciatic nerve |
RGD |
PMID:10603033 |
RGD:2306914 |
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
|
|
G |
APP |
amyloid beta precursor protein |
treatment |
ISO |
|
RGD |
PMID:28446186 |
RGD:13782060 |
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
|
|
G |
CAV1 |
caveolin 1 |
|
ISO |
protein:increased phosphorylation:sciatic nerve |
RGD |
PMID:17234162 |
RGD:2289125 |
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
|
|
G |
CCR1 |
chemokine (C-C motif) receptor 1 |
|
ISO |
protein:increased expression:sciatic nerve, macrophage, T cell |
RGD |
PMID:20500551 |
RGD:5688140 |
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
|
|
G |
CD14 |
CD14 molecule |
severity |
ISO |
|
RGD |
PMID:19162137 |
RGD:2312712 |
NCBI chr 2:35,790,505...35,792,967
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:12864982 |
RGD:2307204 |
NCBI chr37:12,503,849...12,536,362
Ensembl chr37:12,503,811...12,532,854
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:17188497 |
RGD:5491181 |
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
|
RGD |
PMID:17188497 |
RGD:5491181 |
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
|
|
G |
CD59 |
CD59 molecule |
|
ISO |
protein:increased expression:Schwann cell (rat) |
RGD |
PMID:10450801 |
RGD:1600494 |
NCBI chr18:33,977,433...33,999,145
Ensembl chr18:33,977,480...33,998,329
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:18448252 |
RGD:4891968 |
NCBI chr 2:59,022,794...59,032,095
Ensembl chr 2:59,022,794...59,032,095
|
|
G |
CX3CR1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:18448252 |
RGD:4891968 |
NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808
|
|
G |
DCC |
DCC netrin 1 receptor |
|
ISO |
|
RGD |
PMID:16337279 |
RGD:2314374 |
NCBI chr 1:21,788,833...22,494,849
Ensembl chr 1:21,793,328...22,494,967
|
|
G |
DHODH |
dihydroorotate dehydrogenase (quinone) |
treatment |
ISO |
|
RGD |
PMID:11522581 |
RGD:11040446 |
NCBI chr 5:77,756,411...77,766,207
Ensembl chr 5:77,756,407...77,774,090
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
|
ISO |
|
RGD |
PMID:23603807 |
RGD:10395381 |
NCBI chr10:48,550,836...48,636,776
Ensembl chr10:48,551,410...48,634,844
|
|
G |
EPO |
erythropoietin |
|
ISO |
|
RGD |
PMID:20361946 |
RGD:10400894 |
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
protein:decreased expression:sciatic nerve |
RGD |
PMID:30464413 |
RGD:38549576 |
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
|
|
G |
HAVCR2 |
hepatitis A virus cellular receptor 2 |
disease_progression |
ISO |
mRNA,protein:increased expression:sciatic nerve: |
RGD |
PMID:21784136 |
RGD:9686114 |
NCBI chr 4:53,018,990...53,032,035
Ensembl chr 4:53,012,234...53,033,393
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
|
RGD |
PMID:23603807 |
RGD:10395381 |
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
disease_progression |
ISO |
|
RGD |
PMID:17286627 |
RGD:5508466 |
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA, protein:increased expression:sciatic nerve, inguinal lymph node |
RGD |
PMID:10785455 PMID:19207263 |
RGD:4831923 RGD:4888513 |
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
|
|
G |
IL1B |
interleukin 1 beta |
treatment |
ISO |
|
RGD |
PMID:18400050 |
RGD:7401218 |
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
|
|
G |
IL5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:22310911 |
RGD:11522768 |
NCBI chr11:20,825,469...20,827,269
Ensembl chr11:20,825,469...20,827,269
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
|
ISO |
|
RGD |
PMID:9546322 |
RGD:9685357 |
NCBI chr 5:29,187,902...29,196,157
Ensembl chr 5:29,187,851...29,196,153
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:9546322 |
RGD:9685357 |
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
|
| |